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"Orthokeratology is operationally defined as the re-
duction, modification or elimination of refractive errors 
by the programmed application of contact lenses or other 
l 
related procedures." In 1962, at the Seventh National 
Contact Lens Congress the corrective aspect of wearing 
contact lenses were discussed and it was agreed that the 
visual acuity of an individual could be increased through 
a refractive change due to the wearing of contact lenses. 
A survey of the literature revealed that many investiga-
tors have successfully applied various orthokeratology 
techniques to reduce ametropias, but the actual mode of 
action of orthokeratology has not yet been published in 
the literature.2,3,4,5,6,7 
There are many ocular variables to be considered, 
and for purposes of this study approximately 84 variables 
have been considered. These are specified in the section 
on methodology and results. In a long-term study just 
completed several variables were measured and analyzed. 
Some of the more notable observations were the effect 
of different contact lens base curve - cornea relation-
ships on corneal rigidity, induced with-the-rule astigma-
8, 
tism, and variabiltty in the corneal curvature changes. 
9,10,11,12 











at Pacific University College of Optometry. Project I was 
a pilot study lasting for six months which was concerned 
with determining the significance of many refractive tests 
and physical measurements of the eye during orthokeratology. 
Project II, as this study is named, will be a refined long-
itudinal study of Project I and will run over a period of 








Project I included fifteen patients who were randomly 
placed into three study groups: a spectacle control group, 
a contact lens control group, and an orthokeratology group. 
Project II consisted of thirty-two patients: ten contact 
lens control patients, and twenty-two orthokeratology pa-
tients. Ten of the orthokeratology patients were car-
ried over from Project I. The three groups were neces-
sary so that differential changes could be noted among 
standard contact lens patients, new orthokeratology pa-
tients, and continuing orthokeratology patients. The new 
orthokeratology patients herein will be referred to as 
Project II orthokeratology patients. The patients carried 
over from Project I will be referred to as Project I ortho-
keratology patients. Actually, Project I orthokeratology 
patients have a heterogenous background. Some are former 
orthokeratology contact lens patients, some are former con-
tact lens patients 3 and some are former spectacle control 
patients. Thus, they comprise three subclasses of contact 
lens wearers during the Project II phase of the study. 
The patient selection was based on the closest possi-
ble conformity to the following criteria: 
1. Little or no previous contact lens wear; 
2. No previous ocular pathology; 
3. Myopia between land 3D.; 






Following are the actual group profiles at the start of 
Project II. 
Project I Orthokeratology Group 
Six males, four females. 
(Six of these patients were alreading wearing contact len-
ses; three were control contact lens wearers; three were 
orthokeratology contact lens wearers.) 
Mean age: 26.4 yrs.; range: 14 to 34 yrs. 
Mean distance refraction sphere: -2.12 D.; range: -0.75 
to -4.00 D. 
Mean distance refraction cylinder: 0.13 D. with-the-rule; 
range: 0.75 against-the-rule to 0.75 with-the-
rule. 
Mean Keratometer power (flattest meridian): 43.92 D.; 
range: 40.87 to 45.87 D. 
Mean Keratometer cylinder: 0.49 with-the-rule; range: 
0.12 against-the-rule to 1.12 D. with-the-rule. 
Project II Control Group 
Two males, eight females. 
Mean age: 28. 2 yrs.; ra.nge: l~ to 33 yrs. 
Mean distance refraction sphere: -2.32 D.; range: -0.50 
to -4.00 D. 
Mean distance refraction cylinder: 0.13 D. with-the-rule; 
0.87 against-the-rule to 1.00 D. with-the-rule. 
Mean Keratometer power (flattest meridian): 43.17 D; 
range: 41.50 to 46.25 D. 
Mean Keratometer cylinuer: 0.58 D. with-the-rule; range: 
1.00 against-the-rule to 1.62 D. with-the-rule. 
Project II Orthokeratology Group 
Three males, nine females 
Mean age: 23.16 yrs.; range: 15 to 32 yrs. 
Mean distance refraction sphere: -1.76 D.; range: -0.75 
to -3.25 D. 
Mean distance refraction cylinder: 0.13 D. with-the-rule; 
range: 0.75 against-the-rule to 1.00 D. with-
the-rule. 
Mcnn Keratometer power (flattest merldlan): 43.00 D; 
range: 41.75 to 44.75 D. 
Mean Keratometer cylinder: 0.47 D. with-the-rule; range: 
1.00 against-the-rule to 1.62 D. with-the-rule. 
J 
5 
Patients were examined on a bimonthly basis and the 
following tests were performed. 
1. Refractive status and visual acuity by standard 
optometric objective and subjective test battery 
were measured. Six standard te9ts were used to 
evaluate refractive status . . They were: 
visual acuity without contact lenses; 
the distance retinoscopy finding (#4); 




d) the binocular maximum plus to best vi~ual acu-
ity at far ( #7 AB); 
e) the monocular maximum plus to 20/20 at far 
f) the monocular maximum plus to best visual 
acuity at far (#7AM); 
g) the monocular maximum plus sphere (only) to 
best visual acuity at far (#7AMS). 
Note: the visual acuity was also taken for the 
#7AB, #7AM, and #7AMS. 
( #7M); 
2. Ocular anterior segment health was evaluated by 
slit lamp biomicroscopy. 
3 . Contact lens .fit was evaluated by slit lamp bio-
micro~copy, and contact lens parameters were veri-
fied. 
4. Phorias were measured with the Von Graefe techni-









5. Anterior corneal curvature measurements were 
evaluated by central keratometry, ophthalmometry, 
photoelectric keratoscopy with Wesley-Jessen PEK 
and Reynolds Corneascope. 
6. Corneal thickness was evaluated by pachometry 
and ultrasonography. 
7. Anterior chamber depth was evaluated by pachome-
try, ultrasonography, and biomicroscopy. 
8. Anterior and posterior crystalline lens curvatures 
were measured by ophthalmophakometry. 
9. Vitreous depth and axial length were measured by 
ultrasonography. 
10. Intraocular pressure was evaluated by the AO Non-
Contact Tonometer. 
Instruments used in the study were calibrated for accuracy 
and reliability in Project I. The calibration findings 
are listed in the EXPERIMENTAL METHODS AND INSTRUMENTATION 
section of this report. 
The Tabb method of orthokeratology is based on a math-
ematical relationship for increasing contact lens tear 
reservoir by modifying peripheral curves and optic zone 
diameters. Dr. Tabb believes that this method allows 
orthokeratologic changes to occur from hydrodynamic forces 
induced by the tear layer under the contact lens. 






therapy equally, all new patients in Project II were ini-
tially fit with lenses based on the Tabb method of ortho-
keratology. Those patients in the orthokeratology group 
carried over from Project I w~re already wearing lenses 
of the Tabb orthokeratology design. The control patients 
were fit with a 30% tear reservoir; the orthokeratology 
patients were fit with a 32.5% tear reservoir. 
The specifications of the initial lens design are 
listed below. 
Base Curve: The flattest Keratometer reading (hereafter 
referr.ed to aR K ) + 0.25 D. for corneas with 1.00 D. of 
f 
central corneal cylinder or less. For corneas with more 
than 1.00 D. cylinder, the base curve is slightly steeper 
than Kf + 0.25 D., from Kf + 0.50 D. to Kf + 0.75 D. 
Overall Diameter: Kf (in mm.) + 1.0 mm. 
Optic Zone Diameter: This depends on the tear reservoir 
desired. The tear reservoir is defined as: 




If Area = r2, and r = OZD/2, and r = Total Diameter/2, 
1 2 
then 2v OZD = X &otal ~iameter ) 2 
where X= 1- tear reservoir. (Ex.: 1- .325 = 0.675) 
The initial orthokeratology design calls for a 32.5% tear 
reservoir. 
8 
Cept&r Thickness: Standard thickness to standard thickness 
plus 0.62 mm. is recommended. The standard thickness of 
a -2.00 lens is 0.14 mm. and decreases 0.01 mm. for each 
diopter of minus power to a minimum of 0.10 mm. The thick-
ness increases 0.01 mm. for each relative diopter of plus 
power. At times thickness was varied from the above re-
lationship to effect the fit of the lens or the ortho-
keratology effect. 
Power: Power of the subjective #7A. 








= OZR + 1.0 mm. 
= OZR + 2.0 mm. 
= OZR + 3.0 mm. 
(depends upon the tear reservoir) 
= 0.2 to 0.3 mm. 
= 0.3 to 0.4 mm. 
= 0.2 to 0.3 mm. 
Note: The second intermediate curve width was always 
slightly greater than either the first intermediate 
curve width or the peripheral curve width. 
All peripheral curves were well blended to s1mulate 
a near aspheric peripheral area. A blend series was done 
on all lenses. A blend series was defined by lightly 
blending the lens with a tool radius of OZR + 0.5 mm. and 
then lightly blending with a series of tools in 0.5 mm. 
increments from OZR + 0.5 mm. up to OZR + 3.0 mm. The 





water; subsequent blends were done with velveteen pads 
and Silvo silver poliSh. At times it was necessary to 
modify the lens with a tool radius of OZR + 4.0 mm. to 
OZR + 5.0 mm. to promote orthokeratology. 
The initial orthokeratology lens design called for 
a 32.5% tear reservoir. When the unaided visual acuity 
stabilized, the tear reservoir was increased incremen-
tally to 35.0%, 37.5%, and 40.0%, by keeping total dia-
meter constant and decreasing the OZD. No change in 
unaided visual acuity on two consecutive checks signalled 
the change to the next larger tear reservoir. Beyond the 
45.0% tear reservoir, the lens was usually too unstable 
for a proper fit and either a larger diameter was chosen 
based on the new K l3 or the total lens diameter was de-f 
creased until the lens would restabilize. 
Example Contact Lens Design: 
K's: 44.00 #7A : -1.50 D. 
45.00 
Initial Lens Design: 
B.C. (OZR): 44.00 + 0.25 D.= 44.25 D. (7.63 mm.) 
Total Diameter: 7.63 mm. + 1.0 mm. = 8.6 mm. 
OZD: \j 0.675 ( 826 t 2 = 7.1 mm. 
PCR's: 8.6 mm., 9. 6 mm., 10.6 mm. 
PCW's: 0.2 mm.' 0.35 mm.' 0.2 mm. 






EXPERIMENTAL METHODS AND INSTRUMENTATION 
Visual Acuity: Distant visual acuity was measured 
in a clinical examination room under moderate illumina-
tion. A standard AO Projectochart was used at each ses~ 
sian. A reduced Snellen card was used to measure near 
acuities at 16 inches. Unaided acuity among the contact 
lens patients was measured within five minutes of re-
moval of the lenses. Each patient was measured at approx-
imately the same time every session (~ 2 hours). 
Refraction: A standard optometric objective and 
subjective test battery was done at each session. Dist-
ance retinoscopy and a #7A complex (maximum plus to subjec-
tive best vision) was performed on contact lens patients 
with the lenses in place. Then, after the contact lens 
removal, all patients were tested with the following se-
quence of tests: distance retinoscopy; monocular J.C.C. 
(subjective cylinder test); 20/25 equalization; monocular 
and binocular #7 (maximum plus to 20/20); monocular and 
binocular #7A (maximum plus to best visual acuity); mono-
cular #7A with spheres only (#7AMS); distance phoria us-
ing Von Uraefe technique on a row of 20/20 letters; near 
phoria at 16 inches using the Von Graefe technique with 
threshold letters of a reduced Snellen chard; #21 binocular 
blur out and recovery; and #l4B near binocular cross-cylinder. 
(See Recording Form, Appendix B, p. 74 .) 
ll 
S.~A~. Lamp Biomicroscopy: The contact lens fit was 
evaluated with and without fluorescein at each visit with 
a biomicroscope. ( See Slit Lamp Observations form~ 
Appendix B~ p. 73 .) Without fluorescein, the movement 
of the contact lens was estimated by the fast phase of 
the lag upon blinking. The fast phase of the contact lens 
lag was defined as the first position of rest of the con-
tact lens upon blinking. Lens position after the fast 
phase of the lag was evaluated with respect to the center 
of the pupil in two directions: vertical position and 
horizontal position. Decentration of the center of the 
contact lens from the center of the pupil was estimated 
in millimeters (mm.). The vertical position was graded 
0 to 4~ with grade 2 as the vertical position where the 
center of the contact lens would be approximately over 
the center of the pupil. Grade 0 was the most superior 
positioning, decentered two millimeters higher than the 
center of the pupil. Grade 4 was the vertical position 
below the central pupil by two millimeters. The lateral 
position was graded 5 to 9; grade 7 was the centered 
contact lens position over the center of the pupil; 
grade 5 was two millimctcro most nasalward, grade 9 most 
temporalward with respect to the pupil center. Thus, a 











Upon fluorescein installation, the corneal-contact 
lens relatlon~hlp was evaluated, and the tear rcoervoir 
was estimated under lOX magnification. An alignment fit 
was graded as zero; its appearance was defined as an evenly 
thin layer of tears under the optic zone area of the con-
tact lens. (Note Appendix A, Table I, p.63.) Minimal 
apical clearance (MAP) was rated as +1; its appearance 
was as a slight pooling of tears under the contact lens 
optic zone. A moderate clearance lens was graded +2, 
extreme clearance was +3. A flat fitting lens, with a 
central bearing area seen as an absence of tears under 
the center of the optic zone, was graded as to the relative 
flatness, ie., -1 as minimal touch, -2 as moderate touch, 
and -3 as heavy touch. 
The tear reservoir was an estimation (in per cent) 
of the peripheral curve area including the blend area in 
comparison to the total lens area. This was evaluated 
with the aid nf fl!Jorescein. Lenses were cut on the basis 
of a standard formula to attain the desired tear reservoir. 
(Note Experimental Design.) However, the final evaluation 
of tear reservoir was made with the contact lens in situ. 
Intermediate and peripheral curve adjustments were some-
times necessary to attain the desired tear reservoir. 
After the contact lenses were removed, anterior seg-






vations were graded as to the severity of the following: 
corneal edema, fluorescein retention, conjunctival injec-
tion, perilimbal injection, tear break-up time (B.U.T.), 
I 
anterior chamber angle, and any other complications noted. 
(See Appendix A, Table II, p. 64 .) Gonioscopy was not 
performed on any of the patients during Project II. Ant-
erior segment photography was performed on an occasional 
basis, prior to any tonometric or ultrasonagraphic measure-
ments. 
If a finding fell between two grade levels, then it 
was recorded as half-way between the levels. For example, 
the simultaneous presence of superficial foreign body 
stain (Grade 1) and light, punctate staining (Grade 2) 
was recorded as "1.5." The openness of the anterior cham-
ber angle was evaluated on the slit lamp with an optic 
section and the illumination system at approximately 60°. 
A ratio of the apparent thickness of the interval (sha-
dow) of the anterior chamber (lying between the corneal 
optic section and the iris) to the apparent corneal thick-
ness was made. For example, if the width of the anterior 
chamber was three-fourths of the corneal thickness, the 
grading was "0.75 AC/C." 
Keratometry, Ophthalmometry, Wesley-Jessen Photo-
Electric Keratoscopy: Central anterior corneal curvature was 








and WJ PEK. Peripheral corneal topography was determined 
by the "shape factor" of the PEK analysis and the Reynolds 
Corneascope. 
The basic principle of photoelectric keratoscopy is 
the same as kerat.ometry. They both use the relationship 
between a target and its virtual image formed by the cor-
nea. From this relationship, the unknown radius of corneal 
curvature can b'e determined from optical formulas for mir-
ror imagery. The advantage of the Photo-Electric Kerato-
scope is that its target may be composed of many parts 
which act as separate objects whose images may be used 
to measure curvature in all meridians and over a large 
15, 16, 17 
corneal area. 
There are four technical requirements for reliable 
photokeratoscopy. These requirements are theoretically 
met by the Wesley-Jessen Photo-Electric Keratoscope and 
are listed below. 
1. The units used to describe the topography should 
be independedt of the shape being measured. The 
PEK system calculates sagittal depth at various 
chord lengths for two principal meridians. 
2. The instrument should consider at least the total 
area of interest. The PEK analyzes the cornea in 
0.5 mm. increments over a diameter of 9 mm. 




taneously. The System 2000 photographs and computes 
data concerning a large corneal area simultaneously 
4. The total system should have high accuracy and ex-
cellent reproducibility. PEK instruments are 
tested to measure radii of three known spheres 
to within~ 0.015 mm. Reproducibility studies 
18 
show a maximum standard deviation of l/16th D. 
(See Table III, Appendix A, p.67 for the calibra-
tion results on the PEK.) 
The model for corneal form used in the PEK is based 
on shape factor. The shape factor, a factor equal to the 
eccentricity squared, describes the departure of an ellipse 
from a circle. The human cornea has been described as an 
ellipse. A positive shape factor means the cornea flat-
tens in the periphery and describes a prolate curvature. 
A negative shape factor means the cornea steepens in the 
periphery, and this describes an oblate curvature. The 
higher the number, the greater the flattening or steepen-
ing. A shape factor of +0.25 is considered normal. Nolan 
feels that a high positive shape factor is better for 
19 
orthokeratology prognosis than a low shape factor. 
Pachometry: Corneal Thickness and Anterior Chamber 
Depth. A Haag-Streit pachometer and a modified Haag-Streit 
pachometer were used to measure corneal thickness and 






measure the apparent thickness of an optic section of the 
cornea and anterior chamber. When the pachometer is pro-
perly adjusted on the appropriate biomicroscope, the angle 
0 between the light slit and the right ocular is 40 , as 
determined by a bar consisting of a narrow slit through 
which the light passes. The right ocular is lOX and splits 
the corneal image horizontally allowing for a vernier 
alignment measurement technique. After proper alignment, 
thickness or depth can be read from a linear scale. The 
scales measure the rotation of one of the two plane paral-
lel plates of glass, one above the other, which bisect 
the returning light rays. Appropriate corrections need 
to be applied to correct for variations in the corneal 
radius to calculate the actual corneal thickness and ant-
erior chamber depth. 
The Haag-Streit pachometers provide accurate and re-
liable data. Alsbirk found a standard deviation between 
three consecutive readings of 0.007 mm. for corneal thick-
20 
ness and 0.01 mm. for anterior chamber depth. In a 
study of corneal thickness measurements, Lowe found the 
21 
mean corneal thickness of 0.517 ~ 0.003 in 157 subjects. 
Most investigators agree that patient fixation of the 
slit does not insure a perpendicular alignment of the 
slit to central cornea. The patient's visual axis is in 







Since the Haag-Streit pachometers fix the slit on the 
patient's right, asymmetrical measurements are made with 
respect to the two eyes. Differences in measurement by 
0.02 mm. for anterior chamber depth and 0.019 mm. for cor-
22 
neal thickness have been noted. This difference has 
23 
been positively correlated to angle kappa. 
In this study, corneal thickness measurements were 
taken following the procedure listed below. 
1. The pachometer was set up on a Mentor slit lamp 
biomicroscope and the optic section was made as 
narrow as possible. Illumination intensity was 
high and the slit lamp to biomicroscope angle 
was set at 40°. 
2. The patients were instructed to fixate the slit. 
3. For central corneal measurements, the slit was 
first focussed on the iris, bisecting the pupil. 
Then the microscope focus was moved out to the 
cornea and the measurement was taken. The right 
eye was measured first and then the left eye. 
4. For peripheral corneal measurements, the slit 
lamp was moved to the right (nasal for the right 
eye and telllporal for the left eye) and the mea-
surement was made immediately to the right of the 
specular reflection of the bulb filament. 
Anterior chamber d~pth measurements were taken by 
18 
following steps 1 through 3 in the preceeding procedure, 
except the focus of the instrument was maintained in the 
middle of the anterior chamber. Calibrations were made 
on the pachometers ror reliability and the results are 
listed in Table IV, Appendix A, p.68 .. 
Ultrasonography: The Ocular Rerlectoscope was used 
to measure corneal thickness, anterior chamber depth, lens 
thickness, vitreous thickness, and axial length. This 
instrument was engineered and constructed by Automation 
Industries Research Division after the design of Doctors 
Ernest J. Giglio, William M. Ludlum, and Sidney Wittenberg. 
It utilizes a Hewlett-Packard model 175A oscilloscope 
with a 175 A four-channel amplifier. 
The first channel is externally triggered by the 
reflection from the front surface of the cornea, prevent-
ing the pulse to the crystal from appearing on the _screen. 
The channels are sequentially gated and are synchronized 
with the repetition rate of the pulser. The imposition 
of a short variable cal1brated delay at the beginning of 
channel B permits the display of the front and rear lens 
surfaces. Another calibrated delay which can be varied 
from 20 to 40 usee. is interpoocd at the start of channel 
C, thus display~ng the tissue at the rear of the eye. 
This arrangement permits the simultaneous recording of 
the echoes from the eye with a magnification up to 25X 
19 
from the face of a 5-inch cathode ray tube. Magnification 
is limited by the thickness of the lens, and 20X magnifi-
cation is normally used to prevent overlap of channels. 
Channer D carries time marks with a 10 msec. interval 
produced by the 4 mHz. crystal oscillator used to synchro-
nize the entire system. 
The transducer is a partially focussed 20 mHz. lithium 
sulfate crystal 9.5 mm. in diameter with a 2 mm. aper-
ture. It delivers 5 mW./cm~ to the liquid immediately in 
front of the crystal. The transducer has an effective 
beam diameter in the focal plane of 0.304 mm. and spread-
ing to 0.457 mm. one centimeter before and after the best 
focus. The pulse repetition rate is 1953 with a pulse 
duration of less than 0.1 usee. The transducer used in 
this study has been calibrated over a five year period 
24,25 
by William M. Ludlam, O.D. 
The probe standoff is an open-ended, flexible, cone-
shaped device made of clear silicone rubber which fits 
snugly on the ultrasound transducer. Clear silicone was 
needed to visibly inspect for bubbles and discontinuities 
in the fluid comprising the sound pathway. Wall thickness 
decreases toward the narrow opening in three steps to pro-
vide maximum stability with minimum aperture and wall 
thickness at the probe tip so that lashes and lids of the 







The axis at which maximum amplitude reflections occur 
is in the region of the optic axis. In obtaining sound 
measurements of the intraocular distances, reflections 
from the tissue at the rear of the eye is required. The 
optimal sonic axis must be near perpendicular to the re-
tinal curvature as well as the anterior corneal curvature. 
Testing of the present probe indicated that angulation 
0 
of the probe axis greater than + 2 horizontally or verti-
cally for non-mydriatic pupils produces changes in quality-
and amplitude of the resulting echoes which are unaccept-
able. Translation in the horizontal or vertical meridians 
26 
more than~ 0.5 rnrn. also produced an unacceptable result. 
The following procedure was followed in making out 
ultrasonic measurements. 
1. Patient corneas' were anesthesized with one drop 
of 0.5 % proparacaine. 
2. Patients were instructed to keep both eyes open 
and fixate at an object fifteen feet away. 
3. The probe was placed to the eye at the proper 
angle and a water meniscus made contact with the 
eye. 
4. A polaroid picture was taken of the oscilloscope 
trace when all acoustic interfaces were seen. 
Two pictures of each eye were taken: lX picture 






A 20X travelling microscope was used to measure bet-
ween the acoustic relections of the oscilloscope tracings. 
For the anterior cornea, the starting point was 10% of 
the negative phase trace of the first echo. The posterior 
corneal surface was measured at 10% of the positive phase 
trace (mirror image echo). Other surfaces were measured 
the same way using 10% of the phase: 
anterior chamber - start at + phase 
lens - start at - phase 
vitreous - start at + phase. 
(See Table V, Appendix A, p.69 for overall eye and corne~l 
magnification tracings.) 
After the measurements were completed on each trace, 
the following computations were done to determine the ac-
tual millimeter distance through each tissue in the eye. 
1. The distance in millimeters measured between phases 
was divided by a standard velocity (8.2 mm./usec.) 
and the resultant was divided by two (since the 
echo is a measure of a completed round trip). 
The resultant is now in units of time (usee.). 
2. The time in microseconds was then multiplied by 
an assumed vel.oci ty for co.ch tiosue. The assumed 
velocity for the cornea is 1.600 mm./usec. For 
lens it is 1.641 mm./usec. For vitreous it is 










in units of length (mm.). 
To derive vitreous length, one must take into con-
sideration time delay from channel B to C. One-
half of the total delay (13 microseconds) is added 
in step 1 before the final millimeter length is 
calculated in step 2. For vitreous measurements, 
anterior cornea to retina was measured and converted 
into microseconds. The delay was added and then 
the microsecond values of cornea, anterior chamber, 
and lens were subtracted. The final value was 
multiplied by the assumed vitreous velocity. 
4. The corneal, anterior chamber, lens, and vitreous 
thicknesses were then added together to arrive 
at the axial length. 
Photographic Ophthalmophakometry: The method of pho-
tographic ophthalmophakometry is used to monitor changes 
in radii of either the front or back lens' surfaces or both. 
This method is based upon the ophthalmometer principle 
whereby the size of an image produced by reflection of 
an object at sufficient distance from a spherical surface 
is linearly related to the radius of curvature of that 
surface. For a given object, the size of the Purkinje 
image from either lens surface can be measured and com-
pared in size to the Purkinje image of the anterior cor-







corneal surface is known, an apparent radius of curva-
ture of the lens surface may be directly calculated by 
proportion. To calculate the actual radii of curvature, 
the anterior chamber depth and lens thickness must be 
known from independent measurement. This data was provi-
ded from the ultrasonic measurements. 
In the study, the light source used to provide the 
object for the Purkinje images consisted of ·two colli-
mated sources contained in an integral unit so that a 
constant angle is maintained between the two collimated 
beams. The subject was positioned where the two light 
sources intersect, thus providing the brightest possible 
image. Since there are two light sources, two spot 
images will be seen from each reflecting surface. It 
is the distance between the two images which is measured 
and referred to as image size. Since cycloplegics were 
not used, the patient was instructed to fixate at a tar-
get 15 feet away in order to provide a control on accom-
modation. 
A Nikon F camera with a 1:1 macro-lens arrangement 
was used to photograph the first, third and fourth Pur-
kinj e images in order that tl!el.r• .r·ela.tlve sizes could be 
determined. A 20X travelling microscope was used to mea-
sure the image size directly from the film negative. 





was used for calculation. 
The difference between calculated lens surrace curva-
tures and true lens curvatures depends on ~he validity of 
the assumptions made in the calculations and the accuracy 
of the experimental data. For the present experimental 
arrangement, it is likely that some error will result 
from measurement of refracting surfaces which do not lie 
exactly on the visual axis. Another possible source of 
error is the assumed refractive indices needed in the ul-
trasonography and phakometry computations. These assumed 
indices are 1.3333 for aqueous and cornea; 1.4163 for 
crystalline lens; and 1.3333 for vitreous humour. It 
is assumed that these possible sources of error will re-
main constant and therefore should not preclude the deter-
mination of relative changes in the lens power. 
Ludlam, Wittenberg, and Rosenthal 27 · consider that 
a good estimate for the standard deviation of photographic 
measurements to be + 0.02 mm. A mathematical error anal-
ysis shows that accurate measurement of the fourth Pur-
kinje image is the most critical to the calculation of lens 
power and that an uncertainty of + 0.02 mm. results in 
a potential error of + 0.22 D. When the measurement 
uncertainty on all Purkinje spots is considered, the pre-
dicted deviation is 0.27 D. This corresponds to an error 






An experimental evaluation of the reliability of photo-
28 
graphic ophthalmophakometry by Francis found maximum 
variation of 0.33 D. in calculated lens power. Since the 
methods used in this study are similar, these figures 
should be realistic indications of the degree of accuracy 
which can be expected. (See Table VI,Appendix A for ad-
ditional calibration information.) 
Intraocular Pressure Measurement: Tonometry. The 
AO-Non-Contact Tonometer was used to measure intraocular 
pressure on every session. The NCT has been found to be 
relable and accurate. It typically reads 1 mm. Hg higher 
than the Goldman tonometer and 5 mm. Hg lower than the 
29 
MacKay-Marg electronic tonometer. Such factors as car-
diac cycle, cessation of breathing, lid tension, head-
30 
torso position, and anxi~ty can influence repeatibility. 
In this study, patients were measured in the morning 
or · early afternoon, and each patient was measured approxi-
mately the same time at each session (±four hours). 











Data was tabulated for each individual patient. For 
data analysis, patients were separated into three groups: 
1. Project I Orthokeratology: patients carried over 
into Project II from Project I; n = 10 paitents 
(20 eyes). 
2. Project II Control: patients with no previous 
contact lens wear, randomly select~d for subjects 
by criteria set forth in the experimental design, 
and fitted with a standard Tabb lens design with 
a 30% tear reservoir; n = 10 patients (20 eyes). 
3. Project II Orthokeratology: patients satisfying 
the identical criteria for random selection and 
lens fit aR in the Control group, except the ini-
tial tear reservoir was 32.5% and that was subse-
quently increased in succeeding weeks; n = 12 pa-
tients (24 eyes). 
The means of each variable for each session for each 
experimental group were then graphed versus time. 
It should be noted at the outset of data analysis 
that in the study only Project II Control patients and 
Project II Orthokeratology patients were under the close 
control as to baseline data, sta~t of initial fit, and 
subsequent modifications and data measurement. Project I 









backgrounds in terms of contact lens wear; three had been 
fit with Tabb design orthokeratology lenses prior to the 
start of Project II~ three had been contact lens control 
patients in Project I, and four had been spectacle control 
patients in Project I. At the start of Project· II, Project 
I contact lens control and spectacle control patients 
were put on Tabb designed orthokeratology lenses with a 
32.5% tear reservoir. The data for Project I carry-over 
patients is presented in this thesis merely for complete-
ness and it cannot be assessed the same significance as 
the Project II data with the method of analysis used in 
this thes1.s. The significance of Project I data should 
emerge in the master computer analysis, which will cor-
relate each variable with refractive error change and 
visual acuity for each patient and group, all subjects 
equalized over time by assigning time as the start of 
contact lens wear. This analysis is in progress but was 
not available at the writing of this thesis. 
Twenty variables of the 84 measured were selected by 
the research group for analysis after consultation with 
the faculty advisor. The criteria for selection was 
based on which variables showed most change on prelimi-
nary examination of data from individual patients. These 
variables were: 









sured within ten minutes of removal (VA w/o CL); 





0 OEP 7A power in meridian nearest 90 (7A 90); 
0 OEP 7A meridian nearest 180 (7A Ml80); 
OEP 7A monocular sphere only (7AMS); 
OEP binocular cross-cylinder at near (from 7A), 
(14B); 








tion (from 7A), (21R); 
0 Keratometer power in meridian nearest 180 (Kl80); 
0 Keratometer power in meridian nearest 90 (K90); 
0 Keratometer meridian nearest 180 (K Ml80); 
0 Wesley-Jessen PEK power in meridian nearest 180 . 
(PEK 180); 
0 Wesley-Jessen PEK power in meridian nearest 90 
(PEK 90); 
0 Wesley-Jessen PEK meridian nearest 180 (PEK Ml80); 
Wesley-Jessen PEK shape factor in meridian nearest 
180° (PEK e 2 180); 
15. Wesley-Jessen PEK shape factor in meridian nearest 
90° (PEK e 2 90); 
16. Ultrasound corneal thickness, lOX (US CT); 
17. Ultrasound anterior chamber depth (US ACD); 
18. Ultrasound axial length (US AL); 
19. Contact lens peripheral tear reservoir (CL Res); 






Symbols in parentheses refer to notation used in the sub-
sequent tables. Definitions of the data derivations are 
presented in the introduction to this thesis. 
As stated previously, for group analysis of the data, 
patients were analysed separately in three groups: 1) Pro-
ject I Orthokeratology; 2) Project II Control; 3) Project 
II Orthokeratology. For each group, data was graphed for 
each of the 20 variables with time (in wcekB) as the inde-
pendent variable. This method of data presentation was 
selected in order to show how the measurable ocular para-
meters change as a function of time during the progression 
of orthokeratology. This method of presentatlou was se-
lected as being a more complete presentation than achieved 
in the Project I thesis in which primarily initial and 
final values were reported. It also emphasizes the varia-
bility of the data and illustrates where trends can be 
assessed. The disadvantage of this method of presenta-
tion is that it does not allow for· corr'ela ting ehanges 
in variables that occur at different points in time. 
These types of correlations are planned for the master 
computer program analysis which is in progress. 
The data tables were set up with the vertical col-
umns containing vartableR sampled on a specific week. 
The specific variables are labelled in the first vertical 




was taken is labelled at the top of each succeeding column. 
In averaging the data for each group for a given vari-
able, the baseline measurement for each patient individu-
ally was subtracted from the measurement at week X, and 
then the resulting difference values were averaged for the 
entire group to give the data point plotted on the graph. 
This method of averaging was employed for all variables 
except visual acuity because absolute differences in deci-
mal visual acuity are not comparable from the start to the 
end of the project. Therefore, for the visual acuity vari-
able, per cent change at week X was defined as the decimal 
Rcu1ty at week X minus the baseline decimal visual acuity, 
divided by the baseline decimal visual acuity, or: 
test VA - baseline VA 
baseline VA 
This was performed for each patient individually and then 
averaged for each session to yield the group mean. In or-
der to show the variability of the data and hence to point 
out the difficulty in making these types of measurements 
with the currently available instrumentation standard er-
ror bars have been plotted for each data point. These er-
ror bars were plotted as one standard deviation abovA and 
one standard deviation below the mean. Also, they are 
standard deviations for the differences from the baseline, 






ability should not necessarily negate statistical signi-
ficance of the changes. In order to ascertain which changes 
were statistically R1gn1f1cRnt from the baseline data, a 
Student's t-test was performed on the data at each session 
of measurements taking the baseline data for the group as 
one experimental population and the data at week X as the 
second experimental population. Student's t-test was then 
performed on these two populations to yield a level of 
signficance for the change in the variable at week X. The 
level at which the change from baseline was statistically 
significant is indicated on the graph below the error bars 
for each data point. For example, 0.1 under the data point 
indicates that the change from baseline was statistically 
signficant at the 0.1 level but not at the 0.05 level. 
Data is presented in this manner because different inves-
tigators choose different criteria for statistical signi-
ficance. This method of presentation shows the actual 
levels of significance and conclusions can be drawn accord-
ingly. 
The graphs contain a dotted line which indicates the 
change in visual acuity over time and a solid line which 
indicates the change in the specific variable over time. 
This enables one to visually compare the change in visual 













Visual Acuity without Contact Lenses 
This variable was the most significant indicator of 
orthokeratology change of any of the variables measured. 
All three contact lens groups showed an improvement in 
visual acuity over the duration of the study; however, the 
improvement in acuity for the Project II Orthokeratology 
group was approximately four times as large as the improve-
ment in the Project II Control group for the duration 
of the study, except at week 17 where the Control group 
had a much higher level of significance than in the Pro-
ject II Orthokeratology group. The Project I Orthokera-
tology group also showed improvement in acuity, although 
the findings were more variable. The improved acuity in 
the control patients is likely due to an orthokeratology 
effect with the standard Tabb lens. Therefore, the in-
crease in visual acuity is the best indicator of the ortho-
keratol'ogy process with the Tabb method. For the Project 
II Orthokeratology group, the increase in acuity was great-
er than 200% from an average starting acuity of 20/90, 
with several eyes ~eaching an acuity approaching 20/20, 
and two eyes gaining 20/15 in a duration of only 20 weeks. 
The average ending acuity for the Project II Orthokera-







0 0 7A Power in Meridians Nearest 90 and 180 
The 7A ohowed a general reduction on myopia for all 
groups and, as would be expected, the visual acuity in-
creased as the myopia decreased. The Project I group 
showed the greatest variability and the Project II Control 
and Orthokeratology groups showed about the same reduction 
in myopia, approximately 0.75 D. The Project I group 
showed a conoiotcnt decrease in with-the-rule refractive 
astigmatism from the baseline astigmatism of about -0.50 
x 180. The decrease averaged about 0.25 D. refractive cyl-
inder for Project I while the PEK central readings and 
Keratometry readings showed a consistent increase in with-
the-rule corneal cylinder of about -0.25 x 180. The 
Project II Orthokeratology group showed an insignificant 
change in refractive astigmatism---varying between zero 
and -0.12 D. x 180. The central PEK and Keratometry find-
ings showed an overall increase in corneal cylinder of 
about -0.12 x 180. The Project II Control group also 
showed little change in refractive cylinder. During the 
first eight weeks a slight decrease in refractive astig-
matism, less than -0.25 D. x 180, was noted for the Pro-
ject II Control group while Keratometry and PEK findings 
indicated a similar trend in corneal astigmatism. After 
that, the overall variation was small with no particular 











continued to indicate a reduction in corneal with-the-rule 
cylinder. The most significant finding here is that in-
duced astigmatism with this method of orthokeratology was 
essentially non-existant, with, if anything, a slight de-
crease in astigmatism as a result of wearing these lenses,' 
3. ·7 A Monocular Sphere 
This variable was included at the start of Project II. 
The 7AMS as measured was the post-contact lens wear sphere 
power that gave the best measurable subjective visual acu-
ity, not necessarily the spherical equivalent of the :7A 
finding. The results showed a gradual decrease in myopia 
over the length of the study from the baseline. Project I 
Orthokeratology showed a maximum decrease of 0.57 D., 
occurring on week 69. It is evident that the slope of the 
graph tends to parallel the fluctuations of the visual 
acuity although the level of confidence is greater than 
0.20 in most cases. Project II Orthokeratology patients 
also showed a decrease in myopia maximized at 0.46 D. on 
week 20. Again the slope of the graph for the Project II 
Orthokeratology group tends to parallel the fluctuations 
of visual acuity; however, R low lev~l of significance 
(greater than 0.20) was observed during the first eleven 
weeks, thereafter the significance level was higher. Pro-
ject II Control patients also demonstrated a decrease in 





al acuity increase again tends to parallel the slope of 
the 7AMS. With the exception of the greater than 0.20 
significance level on week 3, all the following weeks for 
the Project II Control group indicate a significant dif-
ference from baseline. 
4. PEK Shape Factor 
This variable showed wide variability for all three 
experimental groups throughout the duration of the study. 
Nevertheless, there seems to be a trend toward negative 
changes in the shape factor for all three groups, a trend 
toward making the cornea more spherical (flattening of the 
central cornea and steepening of the peripheral cornea). 
Most of the variability in Project II patients occurred 
during the first eight weeks of contact lens wear, which 
may be a result of adaptation. Project I patients showed 
less variability but it should be remembered that these 
patients were a highly varied population with regard to 
the type of contact lens wear and length of wear. 
Following is a short summary of the three groups. 
Project ! Orthokeratology 
(Average change from baseline) 
Shape Factor in 90th meridian: 
Greatest positive change from baseline = 0.04 
(Week 60) 
Greatest negative change from baseline = -0.12 
(Week 66) 
Ending shape factor = -0.07 (Week 69) 
Shape Factor in 180th meridian: 






Shape Factor in 180th meridian, cont.: 
Greatest negative change from baseline = -0.10 
(Week 69) 
Ending shape factor = -0.10 (Week 69) 
Project II Control 
(Average change from baseline) 
Shape Factor in 90th meridian: 
All negative changes from baseline 
Greatest negative change from baseline = -0.17 
(Week 17) 
Ending shape factor = -0.16 Week 20) 
Shape Factor in 180th meridian: 
All negative changes from baseline 
Greatest negative-change= -0.14 (Week 17) 
Ending shape factor = -0.11 (Week 20) 
Project II Orthokeratology 
(Average change from baseline) 
Shape Factor in 90th meridian: 
Greatest positive change from baseline 
(Week 8) · 
Greatest negative change from baseline 
(Week 11) 
Shape Factor in 180th meridian: 
Greatest positive change from baseline 
(Week 8) 
Greatest negative change from baseline 
(Week 17) 





The general trend indicates that the central cornea flat-
tens while the peripheral cornea steepens. This result 
was also found in the Project I thesis report. 
5. PEK Power in Meridians Nearest 90° and 180° 
Standard deviation of measurements on any given meet-
ing date stayed at about± 0.37 D.; this was certainly 
narrower than the deviation of most of the variables se-







showed a variation in readings of ~ 0.12 D. Several trends 
can be pointed out here. There was a definite trend to-
ward slight flattening of the 180th meridian in all three 
groups. The degree of flattening only amounted to about 
0.25 D., but it did parallel the generally improving acu-
ity as time progressed. The vertical meridian's power 
remained approximately the same for the Project II Ortho-
keratology group, and almost paralleled the horizontal 
meridian's power change in the Project II Control group 
and the Project I Orthokeratology group. With the Pro-
ject I and II Orthokeratology groups, the small increase 
in corneal cylinder (0.25 D.) was due to more flattening 
in the horizontal meridian than the vertical meridian. 
The Project II Control group showed more flattening in the 
vertical meridian, amounting to about 0.25 D. change in 
corneal astigmatism. 
Keratometry 
Central corneal Keratometer finding~ showed little 
change over the duration of the study for any of the three 
groups. There was an overall slight flattening of about 
0.25 D. in the 180th meridian while the 90th meridian 
was essentially unchanged for Project I Orthokeratology 
patients. There was a slight steepening of the 90th meri-
dian by about 0. 25 D. while the 180th meridian w.as essen-






For Project II Control patients there was no overall change 
from baseline. However, even in the orthokeratology groups 
there was no ecncral trenrl P.xhihitP.d in Keratometer find-
ings. The maximum change over the duration of the study 
to date was less than 0.50 D. for any of the three groups. 
As indicated by the significance levels on the graph, 
these small changes from baseline were generally not signi-
ficant. These findings are generally consistent with the 
corneal power changes found with the PEK, indicating that 
measured central corneal power changes do not account for 
the marked increase in acuity. 
Meridians of 0 7A, PEK, and Keratometry Nearest 180 
The mean meridian of the 0 7A closest to 180 varied 
less than 10 degrees on either side of the mean baseline 
horizontal meridian for the two orthokeratology groups 
over this phase of the project. (Seep. 198, 146, 148.) 
The Project II Control varied about 14 degrees on week 17 
from the mean baseline measurement. The horizontal meri-
dional mean obtained from PEK readouts varied within 10 
degrees of the baseline horizontal mean meridian over all 
observations made on Project II Control group. Project I 
Orthokeratology's mean PEK horizontal meridian varied 
about l~ degrees from the baseline mean on week ll; PI'u-
ject II Orthokeratology's mean PEK horizontal meridian 




mean horizontal Keratometry meridian nearest 180° varied 
less than 8 degrees fro~ the baseline mean for all three 
0 
experimental .groups. Thus, the meridian nearest 180 
showed essentially little change over the course of the 
project; there appeared to be no trend in any consistent 
direction of the meridian nearest 180° from the 7A, 
Keratometry, or PEK measurements. 
A. Axial Length and Anterior Chamber Depth 
Axial length showed wide variability with a general 
trend toward shortening. The statistical significance was 
}ow however. The Control group in Project II maintained 
a fairly constant axial length and visual acuity through-
out the 14 week period. The estimated standard deviation 
in reading photographs from the ultrasound unit is 0.05 mm. 
for axial length and 0.09 mm. for anterior chamber. The 
changes that were seen in the data are near the limits 
of readout capability. Considering these limitations, it 
is interesting to note that the Project II Control group 
showed relatively constant axial length and anterior cham-
ber depth, which paralleled the visual acuity recorded 
during the 14 week period that ultrasound measurements 
were taken, while both orthokeratology groups showed a 
trend toward shorter axial length. Anterior chamber 
depth showed litlle overall trend for Project I or II 











9. Corneal Thickness: Ultrasound 
10. 
This measurement showed coocntially no change for all 
three groups. Irregular fluctuations on the order of 
0.01 mm. occurred from week to week with maximum changes 
of about 0.02 mm. Since the estimated accuracy of the 
readout for this measurement is 0.03 mm., no definite 
trends were evident. The apparent trend toward thinning 
of the cornea for the Project I group, although statisti-
cally significant of the 0.01 level, is still within the 
error of measurement and hence not much credulence is 
placed on this trend. 
Binocular Cross-Cylinder at Near ( 14B) 
The binocular cross-cylinder at nearpoint showed only 
a small variation of change from baseline data. The Pro-
ject I Orthokeratology data varied within ± 0.25 D. of 
baseline, with the standard deviation from 0.37 D. to 
0.75 D. Project II Control data varied within 0.37 D. 
from baseline, generally showing a tendency of relative 
hyperactivity of the accommodative system. This trend 
toward greater accommodative activity may be related to 
the associated decrease in myopia (or increase ih the 
hyperopic direction). The findings in the Project I 
Orthokeratology thesis were similar. The Project II Ortho-
keratology group also showed the trend toward greater 











of significance are generally greater than 0.20. 
11. Negative Relative Accommodation at Near ( 21 R) 
The 21 recovery findings (Negative Relative Accommo-
dation at Nearpoint) generally reflected the 14B find-
ings. Here, again, the Project II Control and Orthokera-
tology groups showed a small increase in accommodative 
activity while the Project I Orthokeratology group rev-
eled no particular trend. The change from baseline for 
Project I Orthokeratology varied from +0.40 D. on week 55 
to -0.64 D. on week 57 with an ending value of +0.05 D. 
For Project II Orthokeratology, the change from baseline 
varied from -0.27 D. on week 8 to +0.02 D. on week 14 
with an ending value of -0.02 D. The change from base~ 
line for Project II Control varied from -0.07 D. on week 
17 to -0.71 D. on week 20, with an ending value of -0.71 D. 
It is important, however, to note that any observations 
made about this variable are to be tempered by the fact 
that most mean changes from baseline data were greater 
than or equal to the 0.20 level of significance. 
12. Contact Lens Positioning 
The iniLial contHnt lens pos1tioning of all groups 
tended to be slightly temporal and slightly inferior. 
(See pages 176 & 199,) The mean positioning was within 
0.75 mm. of being centered over the pupil'~ center. 








in Project I versus Project II patients. (See Table on 
p.l99~ Graphs p.l76~) The tear reservoir was consistently 
larger for Project I patients; the lens may thus have been 
less stable. 
Contact lens position appears to be diphasic as the 
orthokeratology effect occurs. The initial contact lens 
position was slightly low. In the first phase, the con-
tact lens position changed from slightly low to slightly 
high with respect to the pupil center. This trend was 
seen in both orthokeratology groups by comparing baseline 
to week 14 (60) vertical contact lens position. (Week 14 
was chosen since the vertical contact lonn pooitioning was 
highest then.) The mean change for Project II Orthokera-
tology during this time was 0.47 mm. and for Project I 
0.79 mm; the mean change for Project II Control was 0.32 
mm.; the Control group's mean vertical position was cen-
tered. Two factors possible causing the position change 
are a contact lens physiological adaptation pro~ess and 
an orthokeratology effect. 
In the second phase, the slightly high vertical con-
tact lens position lowered. This phase was shown by both 
orthokeratology groups between weeks 14 and 20. (See 
Graph p. 17 8. ) The mean lowering for Project II was 0. 31 
mm. and for Project I was 0.21 mm. The Project II Con-
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Tear• R ~ 
The goal 
was 
With a 30% 
tear res e. Patients :r- '-T <:::> ::l.. r and Project II Orthokeratology 
With a 
Patients 32 · 5 % tear reservoir. Among Proj'ect I 
, a f'ew Pat :i_ 
Signed 




start Project II Control patients 
~ :r-1 t s were already wearing Tabb de-
:Lenses of greater than 32.5% tear 
~~a.. :tded visual acuity was fairly 
For thi 






tained at the week 52 level, until a retainer wearing sche-
dule is initiated. The Project II Control patients started 
at a mean tear reservoir of 29.56% t 3.60%, and reanhed a 
tear reser·volL· of 32.17% :!:_ 1. 99% after 17 weeks. This 
occurred because some of their lenses needed peripheral 
modifications to improve their physiological fit; also, 
corneal changes may have tended to increase the apparent 
tear reservoir w1thnllt any modifications being made on the 
contact lenses. As the tear reservoir was increased,. an 
increase in the visual acuity was noted. In the Project 
II Orthokeratology group the tear reservoir started at 
~1.08% :!:_l.87%~ and increased through lens modifications 
and/or induced corneal changes to 34.16% ~ 2.09% after 
20 weeks. The increase in the tear reservoir showed a 
corresponding increase in the visual acuity for the Pro-
ject II Orthokeratology patients. In the Project I Ortho-
keratology group, the mean tear reservoir at week 52 (week 
6 for Project II) was 35.67% ± 2.53%. The mean weekly 
reservoirs varied within 1.00% of baseline tear reservoir; 
this is due to the varied contact lens wearing background 
of patients in this group. At week 66, the mean tear re-
E.ervoir was 35.90% +. l. 53%. ~1 he tHialtled visual acuity 
tended to fluctuate with tear reservoir in these patients. 
There was a greater increase in visual acuity toward the 









constant. This is propably due to those few patients who 
formerly were spectacle control patients and contact lens 
control patients, who were just beginning to develop ortho-
keratology effects. 
14. Biomicroscopy Analysis 
a) Patient Population 
Project II's screening criteria stipulated no previ~ 
ouo ocular pathology. At the baseline observations on the 
patient population some anatomical abnormalities were re-
vealed. Over t~e course of Project II, there were no 
changes in these abnormalities. The observations inclu-
ded the following conditions: bilateral pingueculas, sub-
capsular lenticular stars, intraocular lens vacuoles, 
limbal conjunctival brown pigment deposits, an orange-
colored iris nevus, a wart-like growth of the lower outer 
eyelid, a very light cobblestone lower conjunctival ap-
pearance. One male patient had a chronic internal hor-
deolum in the right lower temporal eyelid. A 30 year 
old female patient had what appeared to be a grayish li-
pid deposit in the anterior corneal stroma; it looked 
like an arcus senilis. 
b) Method of Analysis 
The biomicroscopy findings were evaluated in a dif-
ferent manner than the analytical findings, due to the 







of each grade level in each experimental group was tallied 
over the period from approximately January to November, 
1977. In cases where there was a grade level higher than 
Grade 2, the findings past November l were tallied in or-
der to observe follow-through care and resolution of the 
problem. Thus, the statistics tend to report a higher 
incidence of the higher grade levels. 
The per cent frequency of each grade level was cal-
culated in two different ways. The first method collec-
tively pooled all observations of all experimental groups 
to arrive at an overall incidence of each grade level. 
The second mel;hud puuled only L.he uu::;erval..lons of each 
experimental group together; thus there were three pools 
of data. The per cent frequency of a grade level was 
c~lculated for each group. This effectively equalizes 
each group for direct comparison to each other. 
c) Corneal Edema 
The overall incidence of corneal edema was only 
17.6%; approximately 82% of the time there were no reports 
of any apparent cormeal edema (Grade 0). Seven of the 
22 patients of Project II were edema-free, even during 
contact lens adaptation. In the Project I group, two 
out of ten always had Grade 0 edema; in the Project II 
Control, two out of ten had Grade 0; in the Project II 








The second most frequent grading of edema was Grade 
0.5. It accounts for approximately 12% of the overall 
reports. The incidence of Grade 0.5 in each group waR 
as follows: 8.4% in Project I Orthokeratology, 14.4% in 
Project II Control, and 13.2% in Project II Orthokeratology. 
Edema Grades 0 to 0.5 occurred at one time or another in 
the following number of patients: six of ten Project I, 
six of ten Project II Control, and nine of 12 Project II 
Orthokeratology patients. 
The per cent occurance in each respective group of 
Grade 1 edema or less is as follows: 96.4% for Project I, 
lPO% for Project II Control, and 98.6% for Project II Or-
thokeratology. Thus the Project II Control group never 
had a report of worse than Grade 1 edema, and only a small 
percentage of the other groups did. This was limited to 
six patients and nine observations. At the end of this 
phase of Project II, nine of the ten Project I Orthokera-
tology patients were edema-free. Six of the ten Project 
II Control and seven of the 12 Project II Orthokeratology 
patients were edema-free. All Project II patients were 
reported to have a Grade 1 edema or less by the end of 
this phase of the project. 
The most severe case of edema reported waR Grade 4. 
(See page 64 for key.) This was observed bilaterally in 










last session covered by this phase of Project II, but in 
this instance the case was observed past the closing date, 
in the light of follow-up results.) The contact lenses 
were cleaned; the patient was instructed to limit wear to 
14 hours per day. In a week the edema was resolved to 
Grade 2. A contact lens blend series was performed; in 
two weeks the edema was Grade 1. By the next visit it 
was reduced to Grade 0.5. 
The second most severe level of corneal edema noted 
was Grade 2 by one Project II and two Project I Orthokera-
tology patients. The Project II patient was instructed 
to maintain a regular pattern of contact lens wear; the 
edema resolved itself by the next visit. In general, a 
contact lens blend series was found to clear this level 
of edema. 
d) Fluorescein Retention 
The overall occurance of fluorescein retention was 
36%. There were, however, six patients who never devel-
oped any fluorescein retention (two patients from each 
group). The majority of reported cases of staining was 
approximately divided between light foreign body stain-
ing (Grade 1) and a light, diffuse punctate staining 
(Grade 2). (See Table TT, p. 64 • ) Considering each group 
individually, slightly more Grade 1 than Grade 2 was 








ject II Control and Orthokeratology patients developed 
slightly more Grade 2 (4.5% difference and 3.8% difference 
respectively). 
The most severe case of staining was epithelial dim-
pling (Grade 4) of one cornea. In an effort to improve 
contact lens stability and optimalize the corneal-contact 
lens relationship, the contact lens was reduced 0.4 mm. 
in overall size and a Tabb blend series was performed. 
Within a month all fluorescein retention disappeared. 
The second most severe case of fluorescein reten-
tion was a superficial punctate stain, heavy and co~ 
alesced (Grade 3). This developed in three Project I 
and in two Project II Orthokeratology patients. One 
patient had switched her lenses; with proper placement on 
the respective eyes, the condition resolved itself. It 
was found that, in general, if there was no apparent cor-
neal edema and a corneal-contact lens minimal clearance 
relationship, a Tabb blend series tended to clear up the 
corneal staining. (The Tabb blend series tended to de-
crease the optic zone diameter by 0.1 mm., and sometimes 
0.2 mm.) The presence of an allergy flare-up or cold 
tended to coincide with this level of staining; upon clear-
ing of the flare-up or cold, the fluorescein retention 
tended to reduce itself to a degree without contact lens 





last peripheral curve radius (OZR + 4 mm.) to aide the 
resolution of the staining. If there was a moderate clear-
ance rclntionnhip between cornea and contact lens coinci-
dent with the staining, a light Tabb blend series tended 
to resolve the staining, by increasing the tear exchange 
between the central and peripheral zones under the contact 
lens. The occurance of a light, diffuse punctate stain 
(Grade 2) tended to be resolved most easily by a light 
Tabb blend series on the contact lens, wherein the optic 
zone area was left untouched; this maintained the align-
ment to slight clearance relationship of the contact lens 
with respect to the cornea. 
In review, approximately 70% of the time there was 
little or no fluorescein retention in the Project I and 
II patients over this phase of the project. Approximately 
93% of the time there was little or no corneal edema. 
d) Conjunctival and Perilimbal Injection 
Injection of th~ perilimbal and conjunctival blood 
vessels was at a consistently low level during this pro-
ject. Five patients revealed no change from the pre-
contact lens wearing level of conjunctival injection. 
Three were of the Project 11 Control group, and two were 
of the Project II Orthokeratology group. Of the changes 
noted (about 56%), almost all were of a minimal conjuncti-






p. 65 .) The number of patients per group only developing 
conjunctival injection of Grade l or less were as follows: 
R1X of thA 10 PrnjAct T OrthnkArRtnJngy grnup, all tAn of 
the Project II Control group, and 11 of the 12 Project II 
Orthokeratology group. Thus approximately 97% of all ob-
servations of conjunctival injection were of Grade 1 or 
less. 
Moderate conjunctival injection with moderate chemo-
sis (Grade 3) was noted once in one eye of a Project II 
Orthokeratology patient. It occurred spontaneously; the 
patient remarked that it happened to him infrequently and 
later reported that it resolved within a couple days. 
Moderate conjunctival injection without chemosis (Grade 
' 2) was reported in four Project I patients and one Project 
II Control patient. The injection cleared spontaneously 
in one case where the contact lenses had been switched 
around. An allergy flare-up was coincident with this le-
vel of injection; the patient habitually exhibited low-
grade conjunctival and perilimbal injection. In general, 
it was found that a light Tabb contact lens blend series 
reducing the optic zone by 0.1 mm. or less and/or an over-
all lens diameter reduction by 0.2 mm. tended to re3olve 
this level of conjunctival injection. 
To review, then, the degree of conjunctival injection 





tion with no chemosis (Gradel). In the Project I Ortho-
keratology groups, there was a 6% occurance of moderate 
conjunctival injection without chemosis (Grade 2). In the 
Project II Control group, only one eye developed a Grade 
1.5 injection (counted as 0.8% incidence). In Project 
II Orthokeratology group, only one eye developed a conges-
tion greater than Grade 1; this was Grade 3 (the incidence 
was 0.5%). Conjunctival injection was of a very low de-
gree in the Tabb method of contact lens design, and rela-
tively infrequent in occurance. 
Perilimbal injection was absent in 42% of the obser-
vations. One patient from each experimental group re-
mained free of any perlllmbal injection. Six patients 
from Project I, nine from Project II Control, and 11 from 
Project II Orthokeratology never developed worse than a 
mild congestion of normal limbal blood vessels (Grade 1). 
The worst report of perilimbal injection was Grade 
2, a severe congestion and dilation of the normal limbal 
vessels. This occurred in four Project I patients a total 
of eight times, or 4.8% incidence (in the group's observa-
tion). One patient from each Project II group developed 
Urade 2 injection. One Project II patient developed thio 
on a baseline observation before contact lens wear; through-
out the project he habitually exhibited low grade conjunc-







found coincident with injection; thorough cleaning of lenses 
tended to resolve the injection without contact lens modi-
fication. A Tabb contact lens blend series tended to eli-
minate perilimbal injection or reduce it to a minimal le-
vel (Grade 0.5). 
In summary, only 4.8% of the observations made of peri-
limbal injection of the Project I group were worse than a 
mild injection (Grade 1), and that 4.8% was of a Grade 2 
moderate injection. Only 2.3% of Project II Control obser-
vations were of a mild injection or none at all. Perilim-
bal injection was of a low degree in the Tabb method of 
contact lens fitting, and of infrequent occurance. 
f) Tear Break-Up Time 
The tear break-up time (B.U.T.) appeared to be a nor-
mal 15 seconds or longer in approximately 73% of the ob-
servations made. This is based on the assumption that a 
reading was taken on each eye at each session. All reported 
decreased B.U.T. 's were tallied. Three Project I, one Pro-
ject II Control, and two Project II Orthokeratology patients 
maintained normal break-up times over this phase of the 
study. 
In gener•al, the most frequent reduct ion of the break-
up time was down to the six to ten second range. In each 
group respectively, the per cent occurance of decreased 








The results of this thesis generally reinforce the 
findings of the Project I thesis of 1977. Total corneal 
topography seems to be the major contributor to the mode 
of action of orthokeratology. Of the variable~ considered, 
the best single indicator of the orthokeratology effect 
in Project II was the unaided visual acuity. Change in 
refractive error, although generally paralleling the change 
in visual acuity, was less than expected from tables cor-
. 30 
relating visual acuity with refractive condition. For 
example, the Project II Orthokeratology group had an aver-
age beginning acuity of 20/90 and an ending acuity of 
20/30 while their 7A power in meridians 90 and 180 only 
decreased by about 0.50 D. Central corneal power changes 
were small as compared to the change in the visual acuity. 
Further analysis using Pearson's proguct-moment cor-
relation coefficient indicates that the PEK shape factor 
of the Project II Orthokeratology group correl~tes extremely 












factor (90th meridian) 0.82 
factor (180th meridian) 0.00 
Control 
factor (90th meridian) 0.66 













PEK SHAPE FACTOR VS. VISUAL ACUITY, CONT. 
Coefficient Significance 
Group of Correlation Level =~...;::;:;_ __ _ 
Project I Orthokeratology 
shape factor (90th merid-ian) 





The most likely reason for the eontrol group having as 
high a correlation as was found is because there was some 
orthokeratology effect among these patients as indicated 
by their significant increase in visual acuity. The cor-
relation between shape factor and visual acuity was lower 
for Project I Orthokeratology patients. 
PEK and Keratometer central corneal power measurements 
for all three groups did not show a significant change from 
baseline and thus could not satisfactorily account for the 
changes in visual acuity. Corneal asti~matism changes as 
noted in the results were minimal with no observed trends 
in all three groups. Changes in refractive astigmatism as 
reflected by the 7A were similarly unremarkable. (See 
Tables and Graphs of mean values for PEK, Keratometry, 
7A---first and last~) 
In terms of refractive error, a significant statis-
tical correlation was found between the 7AMS and the vi-
sual acuity for all three groups. (See chart below.) For 
the two Orthokcratology groups, the graphs show that the 
actual increase in visual acuity was significantly greater 







amount of plus sphere change (decrea~e in minus corrective 
3·1 
power) in the 7AMS. The Control group, however, did 
not have a like increase in visual acuity for an equal 
amount of plus sphere change . Perhaps, this is the reason 
for the Control group having a lower correlation between 
7AMS and visual acuity. 
7AMS VS. VISUAL ACUITY 
Coefficient Significance 
Group of Correlation Level 
Project II Orthokeratology 0.89 0.01 
Project II Control 0.68 0.10 
Project I Orthokeratology 0.77 0.05 
Contact lens positioning in the vertical meridian was 
significantly correlated with visual acuity change in the 
Project II Orthokeratology patients (coefficient of corre-
lation (r) = 0.87, at the significance level of 0.02). 
From the graphs, this may be interpreted as meaning that 
well center~d to low positioning lenses of Tabb orthokera- · 
tology design cause an increase in ·visual acuity whereas 
high positioning lenses of the same deRign do not cause 
a visual acuity increase. Horizontal contact lens posi-
tioning of the Project II Orthokeratology group showed a 
poor relationship to visual acuity changes (r = 0.40, with 
greater than a 0.20 significance level). For the Project 
II Control group. both vertical and horizontal contact lens 
positioning showed low correlations with visual acuity 







visual acuity change to produce a doefficient of correla-
tion of only r = 0.18 with a greater than 0.20 significance 
level. Contact lens horizontal positioning correlated with 
visual acuity change to give a coefficient of correlation 
of only r = 0.20 with a greater than 0.20 significance 
level. These lower correlations for the Control group are 
to be expected because this group wore the standard Tabb 
lenses and efforts were made to keep them on the same lens 
design throughout the project. The Project I Orthokera-
tology group had a vertical contact lens positioning which 
correlated with visual acuity change at r = 0.06, with a 
greater than 0.20 significance level while the horizontal 
. 
- contact lens positioning correlated with visual acuity 
change at r = 0.90, with a significance level of 0.01. 
Again, it must be remembered that th~ Project I Ortho-
keratology patients had diverse backgrounds in terms of 
contact lens wear and several of these patients had been 
wearing contact lenses for a longer · period of time than 
the Project II patient population, the longer time period 
perhaps affecting quite different results. 
The change in tear reservoir for the Project II Con-
trol and Orthokeratology groups showed a good correlation 
with increases in visual acuity. For the Control group, 
the correlation between increase in tear reservoir and in-






significance. The Project II Orthokeratology group also 
had a correlation of~ = 0.76 with a 0.05 level of signi-
ficance. This would indicate that the change in visual 
acuity was strongly influenced by an increase in tear re-
servoir. Project I Orthokeratology patients, however, had 
a low correlation between tear reservoir change and visual 
acuity change, r = 0.03 with a greater than 0.20 level of 
significance. 
Of the intraocular parameters measured, only axial 
length of Project I Orthokeratology and Project II Ortho-
keratology groups showed a consistent trend toward short-
ening with the orthokeratology ·process. However, this 
change was generally less than 0.2 mm. and the stat:1.st1.-
cal significance was low. Pearson's product-moment cor-
relation analysis comparing axial length change with vi-
sual acuity change revealed poor correlations with low 
levels of significance. Change in axial length, albeit 
insignificant, would nevertheless support the shape factor 
measurements indicating flattening of the central cornea 
with steepening of the peripheral cornea. Corneal thick-
ness as measured by ultrasound did not show any signifi-
cant change for any of the three groups. 
Biomir.rosr.opy observations of ocular physiology were 
unremarkable for the majority of the patients during the 














served were those occasionally seen in the normal contact 
lens wearing population. It can be said that the Tabb 
method of orthokeratology is as safe as many of the other 












During the course of this project it has been deter-
mined that the most likely explanation for the mode of 
orthokeratology to be a sphericalization of the corneal 
topography. Sphericalization seems to be induced by a 
steepening of the peripheral cornea with a simultaneous 
flattening of the central cornea. This is substantiated 
by the significant visual acuity - PEK shape factor cor-
relation found in the Project II Orthokeratology and Con-
trol groups. All other ocular parameters measured either 
showed little change or no significant correlations to 
visual acuity. 
For the future duration of the project we recommend 
greater emphasis be placed on the total corneal topography 
measurements. With l'egard to ultrasound and PEK measure-
ments, methods to increase precision and repeatability 
are desireable. Also, during the process of manufacturing 
lenses for Control patients, care must be taken that tear 
reservoirs do not exceed the 30% level or orthokeratology 
changes will probably take place. Finally, future re-
searchers in this project might be observant for high posi-
tioning contact lenses in Orthokeratology patients. We 
feel that minimal orthokeratological effects are brought 
about with high positioning lenses. All lenses in the 






low positioning in the vertical meridian if changes in 











Contact Lens Fit Evaluation 
I. Contact Lens Positioning 
Centered lens over the pupil = "27" 
(each number on the diagram represents 1 mm.) 
Position of the lens after the fast phase of the 
lag upon blinking, with respect to the center of 
the pupil. 
II. · Movement 
III. 
IV. 
Estimated in millimeters of movement at the end of 
the fast phase of the lag upon blinking. 
Corneal-Contact Lens Relationship 
+ 3 = Extreme Clearan~P. 
+ 2 = Moderate Clearance 
+ 1 = Minimal Apical Clearance (MAP) 
0 = Alignment Fit 
1 = Minimal Central Bearing (Touch)' 
2 = Moderate Central Bearing 
3 = Heavy Central Bearing 
Tear Reservoir 
Estimation of peripheral curve area including the blend 
area in comparison to the total lens area with the aid 











B. Corneal Edema 
1. Slight amounts, seen as very light gray 
Grade 
0 
haze, limited to less than 10% of the 1 
corneal area. 
2. Moderate amounts, definite grayness to 
corneal appearance, limited to less than 2 
25% of corneal area. 
3. Moderate amounts, definite grayness to 
corneal appearance, limited to less than 3 
50% of corneal area. 
4. Dense edema, heavy grayness in corneal 
appearance, limited to less than 25% 4 
of the corneal area. 
5. Dense edema, heavy grayness in corneal 
appearance, limited to less than 50% 5 
of corneal area. 
6. Other (expaain) 6 
II. Fluorescein Retention 
A. None 0 
B. Foreign body staining, superficial 1 
1.5 =a 
C. Punctate staining, light and variable 2 combination 
of 1 & 2 
D. Superficial punctate staining, heavy and 
coalesced 
E. Epithelial dimpling 
F. Abrasions of the epithelium 
G. Deep corneal abrasions, ulcerations, or 
other severe complications 










III. Conjunctival Injection 
A. None 0 
B. Minimal conjunctival injection, no chemosis 1 
C. Moderate conjunctival injection, no chemosis 2 
D. Moderate conjunctival injection, moderate 
chemosis 3 
E. Severe conjunctival injection, no chemosis 4 
F. Severe conjunctival injection, moderate 
chemosis 5 
G. Severe conjunctival injection, severe chemo-
sis 6 
H. Other (explain) 7 
IV. Perilimbal Injection 
A. None 0 
B. Mild congestion and dilation of limbal ves-
sels which was not characteristic of the 1 
prcfitting condition. 
C. Severe congestion and dilation of the nor-
mal limbal vessels. 2 
D. Conjunctival hyperemia (chemosis) 3 
E. Other (explain) 4 
V. Tear Break-up Time 
A. Evaluated as time in seconds before first 
indication of tear break-up on the cornea, 
normal being 15 seconds or longer. 
VI. Anterior Chamber Angle 
A. Estimated as the anterior chamber thickness 
to corneal thickness ratio when measured at 
the limbal margin wieh the ocular-illumina~ 
tion angle set at 60 . An open angle ratio 







VII. Other Complications 
A. None 











I. Steel ball- 7,JJrnm = .1.;.6.06 D 




















II. Steel ball - 7. 67rnm = 44. 02 D 
shape factor= 00.00 
















III. Steel ball- 8.00mm = 42.20 D 
shape factor= 00.00 
?~K measurements: 42,23 7.99 
42,12 8. 02 
42.12 8, 02 
42.13 8. 01 
42,0~ 3.0) 
42.0S A.O) 
L!-1. 99 e' QLj. 



























shape factor: mean= • 037 std. dev. 1 . 0277 var.' • 0007) 
IV. Human subject- R. Holling o.s. 
P2K Ophthalmometer 
H sf v sf H v 
4).8_5 0.22 L;.4, 44 0.19 ·J115 ~~ J. 62 44 . .50 @92 
l}). ?6 0.33 /~ . 4, L}2 o.ho 2>090 lj.J. 62 44.75 @92 
4),96 0.?. 6 41}. 4 3 0,22 :fP 12 0 4J.75 44.62 @90 






Corneal 'l'hir.l·~r.es s Fac h ometry 
~en~or slit lamp # 7))16 
O.D. mm O.S. mm 
.s J .515 
t' "> 
• ') 1:. .515 
r'0 ~ 
• .J i, ) .515 
'"3 . _) . 515 
.52 .515 
.52 5 .)25 
.sJ .53 
. _53S .52 
, .. ~ ) c: 
. ) , _ _) 
.525 
.')2_5_ ~ 
mean .527 .520 
variance . 00002 .0000) 
st. dev. . 0047 . 0055 
O.D, - O.S. = +.007mm 
1.1 m 
Anterior C h<l m:--Jt~r De nth Pachom8try 
Mentor slit lamp lf 73316 
* O.D. 0. s. lll ffi mm 
J,)O J. 61 ).5 8 ).62 
~ sr ). -' ).62 
J.) H 3.61 
J r: 7 
, .I 3.62 
3. S!.J- 3.61 
).52 3. 61 J ,- t' 
. ) .) J.62 
J.52 ).59 
·lill ~ 
mean ) • 511-2 ).612 
variance .OOC68 . , 00009 
::.:;t. de;v, , U2 G2 • 009'( 
O.D.m- O.S.m= -.070mm 
68 
subject - R.H. 
t/25) 
O.D. mm 0 0 s. mm 
. 505 o515 





. 505 o515 
. 505 .515 
. 505 .52 
~ . 515 
• 507 .515 
. 00002 • 00004 
. 0048 • 0062' 
= -.008mm 
#253 
O.D. mm o.s. mm 
J.52 J. 61 
).54 ).59 
J.56 3 • .57 
J.so 3.60 
J.52 3.61 
3. 50 3. 61 
J.54 3'• 59 
J.so 3. 61 
3.53 · 3.61 
L.2. .1& 
).523 3.601 
• 00045 0 00018 
. 0212 . 01)8 
= -.078mm 
* data taken from instrument scale and has not been 
corrected with corneal curvature charts. 
. , 
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t:X : . ~a,-; 
l20X r· .. tag 
Corneal Thickness c 











· • } . 
·i· 
' 
= Lens thickness 
. . 
= Interval needed for .. 
Vitreous computation ~:{ . .. , 
, . 
.. 
l . ... TA3L~ v-a 
70 
l U 1 tras on o,-~r-aphy Calibr <J. ·~ions 
l ;,..•; 
Subject- f~ • ](. O.D. 
. . 
l mm's Cornea 0.580 0.58J 0. 512 0.581 0.553 
l Ant. Chambr:r J. 054 J .186 ),278 3.092 3. 044 lens /.j .• 12 0 4.029 4. 011 4.088 4.09) 
Vitreous 16.)00 16.168 16.1L~2 16.179 
Axial Lenr;th 24. 054 2).966 2J·. 943 23.940 .. 





mean variance std, dev. ·, 
' . 
Cornea 0,5618 0,0007 0. 0270 
Ant. Chamber J. 1525 0,0075 0.0869 
. . 
Lens 4. 062 0 0.0019 0, 0439:<. 
Vitreous 16.1972 0.00)6 0,0608 
. .. 
Axial Lenr;th 2).9?57 0,0021 o. 0462 .. 
Corneal iv!ag 0,5855 0,0000 0.0022 
.. : : 
_j 

















QPE'l'HA U10H! A.K ·)~ .. ·:'rRY. 
Curvature: 6.80 D 
~) td. Dev: . 0530 
variance: . 002R 
Len;3 Curvature: 1).60 D 
Std. !Jev: ,2000 
variance: . 0400 
Total Lens Power 20~14 D 
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Name ---------- RECORDING FORM 
ORTHO-K PROJECT II 
C.L. WEARER 
DATE DATE 
# History: History 
VA OD: VA OD: 
-
-cc OS: cc OS: 
OD: OD: OR: OR: OS: OS: 
SLE: See Additional Form SLE: See 
OD I @ OD 
K: K: 
OS I @ OS 
VA OD: VA OD: 
-sc OS: -sc OS: 
S: OD: S: OD: 
OS: OS: 
OD: 7B OD: 7B OS: OS: 
OD: VA OD OD: OS 7AB 7AB #2 ou OS: OS: 
OD: OD: 7M 7M OS: OS: 
7AM 00: VA OD: 7AM OD: 
OS: #67 OS: OS: 
00; VA OD: OD: 7AMS OS: 7AMS #68 OS: OS: 
#8 NVA OD: #8 
CC 7AB 
#13B #3 OS: #13B 
#21B NET #21B NET 
#21R NET #21R NET 













C.L. Verification C.L. Verification 














# OD OS 
44 I I AC/C 
45 I I Edema 
I I Fluorescein 46 Retention 
.I 47 l I I BUT 
48 I I ~--] Injection 
I I I Perilimbal 
J 
49 Injection 














Position After Fast 











Position After Fast 





















NAME T DATE: 
OD OS 00 0~ OD 05 OD 05 CD 
QPHT~ AL-MOMETRY 
(.'-C. C! @ ~ @l @ @ ~ @ @ 
PAC\o\OMET~'( 
Mk~~ •• u~.ep 
< C. copgec.TEo 
lli 
~ MEA:)iARED 
P. CO~Rec. reo 
-I 
en ME' A.S\AREO 
~ ~,; CORRE,TED %,4: 
,<E -'T~UE 
PkA~OMET~'r' 
V' IF D(.)~E 
PEK >/ lF OO'JE 
\ONOMEiR.'C" 
~LTR~'SOHObAA.VW~ 
./ IF DOtJE'" 
(I X') c. T. 






../ IF DONE: 
COMMENTS 
-
--- r- - --- ---- - --- - --- - --- --- ~ 
OS c!'D OS 
@ @ !I 
I 













Week No . 













PEK e 2 180 
l PEK e2 90 
u.s. CT 
I u.s. ACD 
l u.s. AL 
CL Res. 
I CL Pos. 
J 
Bas e l i ne 
0.067 
-4.00 




























































63 66 69 72 
0 . 2 




















Week No. !Baseline 52 
VA w/o CL 0.067 0.1 
7A 180 -3.50 -3.00 
7A 90 -3.75 -3.25 
7A Ml80 014 165 
7AMS -3.50 
14B +.50 +.75 
21R +2.50 +2.50 
K 180 44.75 44.75 
K 90 45.50 45.50 
K Ml80 180 004 
PEK 180 44.90 45.05 
PEK 90 45.41 45.20 
PEK M180 180 160 
I PEK e 2 180 .51 .25 
I PEK e2 90 .26 .21 
u.s. CT . 555 
u.s. ACD 3 . 18 
u.s. AL 24.38 
CL Res. .35 
















































Week No. !Baseline 52 
VA w/o CL 0.67 0.67 
7A 180 -1.50 -1.25 
7A 90 -1.50 -1.75 
7A Ml80 180 30 
7AMS -1.50 -1.50 
14B +2 . 00 1.25 
21R +3.00 2.25 
K 180 40.87 40.50 
K 90 41.75 ·. 41.50 
K Ml80 90 95 
PEK 180 41 . 01 40.70 
PEK 90 41.45 41.39 
PEK Ml80 95 180 
PEK e 2 180 0.22 0.05 
PEK e2 90 0.13 0.18 
u.s. CT .642 
I u.s. ACD 3.79 
1 u.s. AL 24.51 
CL Res. 0.37 













40.37 40 . 25 
41.12 41.12 







3.042 2. 96~ 










































I K 90 
K Ml80 
I PEK 180 
I PEK 90 
PEK M180 
I PEK e 2 180 
j PEK e2 90 
u.s. CT 
































































































PEK e 2 180 
PEK e2 90 
u.s. CT 
u.s. ACD 
I u.s. AL 
CL Res. 




































. ··018 ~ 010 




















0.75 . 0.50 
1.75 2. 25 '1 
45.00 45.50 
























































PEK e 2 180 























































60 63 66 69 72 
0.40 0.80 0.50 
-0.75 -0.50 -0.75 
-1.25 -1.00 -1.25 
140 150 140 
-1.00 -0.75 -1.00 
0.75 0.50 1.00 
1.75 2.25 1.25 
45.00 45.25 45.75 
45.75 45.75 46.25 
165 180 179 
45.16 .45.08 45.79 
45.64 45.54 46.24 
-" 
155 160 005 
0.13 -0.10 0.11 ' 
' 




0.34 0.33 0.33 




















\ PEK e 2 180 
I PEK e2 90 
u.s. CT 
l u.s. ACD 
I u.s. AL 
CL Res. 






























































Patient R. D. ~~~-------------Eye T.EFT 
Age 29 
Sex M 
60 63 66 69 72 
• 3( .a .a .a .a 
-2.75 -2.25 -2.00 -1.50 -2.25 
-3.00 -2.00 -2.00 -1.00 -1.75 
25 160 180 180 145 
-3.00 -2.12 -2.25 -1.75 -2.00 
1.75 .so 1.00 1.75 .so 
2.75 '1 2 o 50 2.75 2.75 2.25 
45.75 46.50 46.50 46.50 46.50 
47.25 46.25 46.00 46.50 46.25 
laO 1aO 20 1aO 180 
46.10 · 45.99 46.72 46.2a 
46.54 46.44 45.97 46. 3.6 
160 180 140 180 
.16 -.09 .16 -.03 j 
.25 .03 .08 -.06 
o SH .525 
3.692 3.714 
24.060 24.219 
.33 .37 .37 .37 • 38 




















PEK e 2 180 














































-3. 5( -4o25 






















60 63 66 69 72 
, 2E .33 .4 .3 .5 
-2.2: -2.25 -2. 0( -2.25 -1.75 
-2.7: -2.00 -2 .0( -2.25 -1.50 
20. 10. 180 180 175 
-2.2!: -2.12 -2.2: -2.00 -2.00 
1.7!: .so 1.0( 1.75 .so 
2.7: 2.50 2. 7: 2.75 2 .• 25 
45.75 46.25 46. oc 46.50 46.50 
46.25 46.00 46.0( 46.25 46.00 
150 180 180 180 180 
45.90 . 46.07 46.12 46.08 
46.14 46.43 45.96 46.22 
165 30 165 180 
.11 .14 .16 .08 I 
.20 .17 .22 .10' 
.51 .533 
3.64 I> 3.686 
23.97 24.096 
.33 .35 .37 .37 .38 
27. 27. 28. 28 •. 28. 
Week No. 











I PEK 90 
PEK Ml80 
! PEK e 2 180 
j PEK e2 90 
u.s. CT 
I u.s. ACD 
















































60 63 66 69 72 
0.5 0.5 0.8 1 . 
-0.75 -1.25 -1.00 -0.50 
-0.75 -1.25 -0.50 o. 
180 180 175 170 
-0.75 -1.25 -1.00 -0.25 
+0.75 +1.00 +1.00 +1.00 
+2.00 +2.50 +2.50 +2.00 
44.50 44.50 44.00 44.00 
45.00 45. oo· 44.75 44.75 
180 180 180 180 
44~25 44.00 43.00 44.25 
44.75 44.37 43.75 45.00 
20o 20. 180. 180. 
0.06 0.16 -0.02 0.11 I 
' 




0.35 0.35 0.375 0,375 
















I PEK 180 
I PEK 90 
PEK Ml80 
I PEK e 2 180 
l PEK e2 90 
u.s. CT 
1 u. 5. ACD 






. 1 .oo 
1-0o 75 
180. 








































Patient L . s. --~-=~-----------Eye RI GHT 
Age 34 
Sex F 
60 63 66 69 72 
0.67 0.5 0.5 0.67 
-0,75 t-1 0 25 -1.25 t-1.00 
-o . 5o -1.25 -0.75 -1 . 00 
150. 180. 5. 180, 
-1.00 -1 . 25 -1.25 -1.00 
+0.75 +1.00 +1.00 +1.00 
+2.00 +2.50 +2.50 +2 . 00 
44.50 44.50 44.25 44.25 
45.00 45.25 44.75 44.75 
180. 180. 180. 180 • 
44.12 44.25 43 . 00 44.25 
44.37 44.87 43.25 45.12 
20. 175. 175, 180. 
0.28 0.16 -0.03 0.03 1 
o : 2 0.25 -0.08 0.15 
0 . 501 0,479 
3.606 3o518 
23.284 23.345 
0.35 0,35 0.375 0.375 



















PEK e 2 180 











-1 . 50 
f+l.OO +1.50 
rt-2.25 +2.50 




~4 . 69 44.64 
170 30 
.18 -.10 
.03 - .. 01 
.498 .465 
3.582 3.585 














44 . 50 45.00 















































































PEK e 2 180 
































































































Week No. !Baseline 52 
VA w/o CL .067 .so 
7A 180 -2.50 -2.25 
7A 90 -2.50 -1.25 
7A MlBO 180 180 
7AMS -2.50 -2o25 
14B .75 2.00 
21R 2.25 3.00 
I K 180 45.62 45.2S 
I K 90 
46.50 46.SO 
K MlBO 180 180 
I PEK 180 45.82 45.18 
l PEK 90 46.45 46.11 
PEK MlSO 125 005 
I PEK e 2 180 .09 -.04 
PEK e2 90 .15 -.10 
I 
u.s. CT .610 .509 
u.s. ACD 3.356 
u.s. AL 23.07 
CL Res. .40 






















































































PEK e 2 180 





j CL Pos. 
J 
Baseline 52 
. 1 .33 
































. . ' 180<' 180 
45.52 45 . 61 






22.98 22 . 86 
.40 . 35 
38 27 




60 63 66 69 72 
1.33 1.00 
-1 . 25 -. so 




3 . 25 3,00 
45 . 25 45.50 
45.50 45 . 75 
180 180 
.45 . 35 45 . 50 
45.60 45.51 
40 180 
.os .02 I 
·' 




Week No. !Baseline 52 
VA w/o CL .33 1.0 
7A 180 -1.25 -.so 
7A 90 -1.50 0 
7A MlSO 010 150 
7AMS 0 
14B 1.37 .75 
21R 2.50 2.75 
K 180 42.00 41.00 
K 90 42.25 _41. 25 
K Ml80 1?9 180 
PEK 180 41.96 41.33 
PEK 90 42.37 41.82 
PEK Ml80 05 180 
PEK e 2 180 .16 -.05 
j PEK e2 90 .20 -.06 
u.s. CT .538 
I u.s. ACD .343 3 . 308 
I u.s. AL 25.446 24.846 
CL Res. .4 




























Patient -~M~· ~s~·~----------­Eye LEFT 
Age 31 
Sex 



















Week No. Base line 52 
VA w/o CL .33 1.0 
7A 180 -1.25 -.so 
7A 90 -1.50 -.50 
7A M180 170 15 
7AMS -.25 
14B 1.37 . 75 
21R 2.50 2.75 
K 180 42 . 12 41.50 
K 90 42.3? 41.50 
K Ml80 179 160 
PEK 180 42.04 41.49 
l PEK 90 42.46 41.97 
PEK M180 180 145 
I PEK e 2 180 .12 .06 
J PEK e2 90 .13 .09 
u.s. CT .546 
I u.s. ACD 3.397 3 . 433 
1 u.s. AL ~4.975 42 . 816 
CL Res. .4 




























Patient M.s . Eye ~R=I~G~H~T-------------
Age 31 
Sex M 
60 63 66 69 72 





1 . 50 
2 . 75 




























I PEI< 90 
PEI< Ml80 
I PEI< e 2 180 
I PEK e2 90 
u.s. CT 
l u.s. ACD 
j u.s. AL 
CL Res. 






























































Patient R. N. ~~~~-----------Eye LEFT 
Age 28 
Sex M 
60 63 66 69 72 
0.40 0.40 0.40 
-2.00 -2o25 -1.25 
-2.00 -2.25 -1.75 
180 180 023 
-1.75 -2.50 -1.75 
+1.25 +1.00 +1.00 
+3.00 +2.25 +2.75 
41.50 41.25 40.75 
42.00 41o62 41.25 
150 180 180 
41.16 ~1o22 40.97 
42.21 42.15 42.02 
160 170 155 
0.30 0.40 0.28 
, 




0.38 0,40 0.35 
37 37 19 
1 
Week No. !Baseline 52 55 
VA w/o CL 0.2 0.33 
7A 180 -2.50 -2.25 
7A 90 -2.75 -1o00 
7A Ml80 005 155 
7AMS -2o00 -
14B +1.25 +0.25 
21R 2.75 +1.75 
K 180 41.00 41.50 
K 90 41.75 .41. 50 
·-
180 180 . K Ml80 
PEK 180 41a09 40.93 
I PEK 90 41.63 41.27 
PEK Ml80 005 020 
I PEK e 2 180 0.32 0 • .28 
PEK e2 90 0.29 0.18 
u.s. CT 0.494 
J u.s. ACD 3.371 
l u.s. AL 25.676 
CL Res. 0.35 





























60 63 66 69 72 
0.40 0.33 1.33 
-2.25 -3.00 -0.25 
-2a25 -2.00 
180 165 150 
-2.00 -2.25 -o.so 
+1.25 +1.00 +1.00 
+3.00 +2.25 +2.75 
41.75 41.75 41.00 
41.75 42.00 40.87 
180 180 180 
41.05 ·41 D 59 41.23 
41.84 41.92 41.36 
015 180 010 
0.26 0.34 0.40 ' 
.• 




0.38 0.40 0.38 







VA w/o CL 
7A 180 





I K 180 
I K 90 
K Ml80 
I PEK 180 
l PEK 90 
PEK Ml80 
1 PEK e 2 180 
I PEK e2 90 
u.s. CT 
I u.s. ACD 
I u.s. AL 
CL Res. 
--' CL Pos. 
J 
















-2 . 50 




































-1 . 75 -2 . 00 
-3.00 -3.00 
180 170 
-2.25 -2 . 50 
1.25 .75 
2.50 2.75 
43.50 4 3.62 

























I PEK e 2 180 
I PEK e2 90 
u.s. CT 
1 u.s. ACD 
I u.s. AL 
CL Res. 
j CL Pea. 
J 






































63 66 69 72 
.2 .2 .2 
-2.25 -2.00 -2.00 
-3.50 
-1.25 -2.75 
180 180 45 
-2.87 
-2.50 -2.37 
1.75 1.25 .75 
3.50 2.50 2 •. 75 
44.00 44.00 43.75 
45.25 46.25 45.50 
180 180 180 
I 
. 
.32 .32 .32 


















PEK e2 180 









































































11 14 17 20 23 
0.33 0.29 0.40 0.285 
-2.75 -3.25 -3.25 -2.50 
-2.00 -2.50 -2.00 -2.25 
165 180 175 150 
-2.50 -2.75 -3.00 -3.00 
+1.00 +0.50 -0.50 +1.25 
2.75 2.50 3.25 2.50 
I 
44.00 44.25 43.87 44.37 
44.00 44.00 43.87 43.75 
010 177 . 
43.78 44.44 44.01 44.07 I 
43.75 43.74 44.14 44.17 
005 140 145 180 
.24 .44 .o8 .04 




32.5% 32.5% 37% 37% 
28 38 38 38 
1 
1. 
Week No. !Baseline 
l 
VA w/o CL 0.2 
7A 180 -4.00 
7A 90 -3,50 




K 180 43 . 75 
K 90 43.75 
K Ml80 
PEK 180 44.35 
PEK 90 44.32 
PEK MlBO 170 
PEK e2 180 .16 
PEK e 2 90 .09 
u.s. CT .487 
u.s. ACD 3.176 


































+2.75 2 . 25 





.06 . 11 
. 19 .22 
.499 . 491 
3.127 3 . 105 







11 14 17 20 23 
0.33 0,29 0.29 0.29 
-2.25 -2.75 -2.75 -2.25 
-1 . 50 -2.25 -1.75 -2.00 
020 007 030 030 
-2.25 -3.00 -3.00 -3.25 
+1.00 +0.50 -0.50 +1,25 
2.75 2 . 50 3 . 25 2.50 
I 
44 . 25 44,00 44.25 44.25 
44.25 44.25 44.12 . 44.00 
002 178 180 
44.10 43.97 44,54 44 . 56 I 
44.43 44.44 44.12 44.20 
010 015 145 160 
.18 .17 -.10 .16 
.20 . 34 -.12 .13 
.499 . 493 
2.799 3.160 
22.91 23.32 
32.5% 32.5% 37% 37% 

















PEK e 2 180 




















































Patient _ _.~,u..T ._. _.P._. • .__ ____ _ 
Eye LEFT 
Age · 30 
Sex 
























Week No. ~se1ine 3 
VA w/o CL 0.24 Oo29 
7A 180 
-2.00 -2.50 
7A 90 -2.37 -2.50 
7A M180 003 180 
7AMS -2.25 -2.50 
14B 1.25 1.25 
21R 2.75 2.00 
K 180 42.87 42 .. 75 
K 90 43.50 43.25 
K JUB~Q 001 170 
PEK 180 43.28 41o09 
PEK 90 43.89 41.34 
PEK Ml80 175 175 
PEK e2 180 0.42 0.26 
PEK e 2 90 0.41 0.26 
u.s. CT 0.558 0.570 
u.s. ACD 3.615 3.793 
u.s. AL 25.061 25.041 
CL Res. 0.30 
























47.0 27 .. 0 
11 
Patient J. P. ~~~~-----------Eye RIGHT 
Age · 30 
Sex F 








































PEK e2 180 
































































































PEK e2 180 













































































28 28 ' 
l 
Week No. !Baseline 3 
VA w/o CL o33 .33 
7A 180 -1o25 -1.75 
7A 90 
-1.00 -1.25 
7A M180 180 05 
7AMS -1.12 -1.25 
14B 1.25 1.25 
21R 2o50 
K 180 42.50 42.75 
K 90 42.25 42.75 
K 1U80 180 180 
PEK 180 42.04 42.-49 
PEK 90 42.36 42.52 
PEK Ml80 10 170 
. J PEK e2 180 o29 .29 
PEK e 2 90 .32 .13 
u.s. CT .511 .525 
u.s. ACD 2.593 2.962 
u.s. AL 23.782 24.309 
CL Res. .32 


























14 17 20 . 23 






















Week No. !Baseline 3 
VA w/o CL o2 .2 
7A 180 -2o00 -2.25 
7A 90 -2.00 -2.25 
7A M180 180 180 
7AMS -2.25 -2.25 
14B 1.25 1.25 
21R 2.50 
K 180 42.50 42.50 
K 90 43o00 43.00 
K Ml80 180 180 
PEK 180 42.15 42.21 
PEK 90 42.81 42.62 
PEK Ml80 175 175 
PEK e 2 180 .14 .17 
PEK e 2 90 .21 .15 
u.s. CT .507 .524 
u.s. ACD 3.150 
u.s. AL 24o679 
CL Res. .32 
































































PEK e2 180 























































11 14 17 20 23 
,067 0,1 0.1 
-3.50 -3.25 -3.00 
·-3.75 -3.75 -3.25 
.15 180 145 
-4,00 -4,00 -3.25 
+1.00 +1.75 +1.50 
+2.25 +2.50 +2.75 
I 
4325 43,00 42.87 
43.50 43,37 43,50 
180 180 180 
42.87 42.62 l 







0.3 0,325 0,3 























PEK e2 180 














































o. 50<!! 0.4.97 








































































PEK e2 180 












-0 .. 25 
+1o25 
42 .. 37 
43oSO 
8 

































.. 40 .40 
-0.7S -0 .. 7S 





42,00 42 .. 12 
42.75 42 .. 75 
180 180 














11 14 17 20 23 
.so .so .so .2S 
-0.7S -1.00 -1.2S -1.2S 
-0.7S -0.7S -1.00 -1.00 
180 160 150 140 
-1.00 -1.12 -1.37 -1.12 
+1 .. 00 +0.50 -o.5o -0.25 
+2.00 +1.50 +1.75 +1.00 
I 
41 .. 75 41.75 41.75 42.00 
42.62 42.87 42.87 42.75 
180 178 5 18 
41 .. 98 41.87 42.09 42.11 ' ' 
42.79 42.63 42.76 42.60 
10 10 180 180 
o16 o24 .26 .22 
.09 o19 .13 .01 
.528 .. 521 
3.377 3 .. 389 
24.114 24.069 
30 35 32 30 
18 27 37 ' 17 
.l 
Week No. !Baseline 3 
VA w/o CL .40 .so 
7A 180 -0.75 -1.50 
7A 90 -1.00 -1.25 
7A M180 10 25 
7AMS -1.12 -1.12 
14B -0.25 +0.25 
21R +1.25 +1.25 
K 180 42.37 42.50 
K 90 44.00 43.75 
K _M_l80 7 179 
PEK 180 42.37 42.13 
'• 
PEK 90 43.66 43.11 
PEK Ml80 5 175 
PEK ·e2 180 
.34 .15 
PEK e 2 90 .18 .09 
u.s. CT .528 .538 
u.s. ACD 3.301 3.365 
u.s. AL 24.110 24.051 
CL Res. 30 































11 14 17 20 . 23 
.67 .67 .40 .25 
-0.75 -0.75 -1.00 -0.50 
-1.25 -0.75 -1.25 -0.75 
180 180 165 148 
-0.75 -0.75 -1.12 -0.62 
+1.00 +0.50 -o.5o -0.25 
+2.00 +1.50 +1.75 +1.00 
I 
42.00 41.75 41.87 42.12 
43.00 43.00 43.00 43.25 
180 176 2 178 
41.91 41.95 41.96 41.90 I 
43.29 43.20 43.20 43.11 
180 180 180 180 
.26 .13 .25 .35 




31 35 32 30 


















PEK e2 180 










































































Week No. Baseline 3 6 
VA w/o CL .1 ol 
7A 180 
-3.00 -3o00 
7A 90 -2.50 -2.75 
7A M180 180 180 
7AMS -3.00 -3.00 
14B 1o00 .75 
21R 2.50 1.50 
K 180 42.75 42.50 
K 90 44.00 43.50 
K Ml80. 180 180 
PEK 180 42,66 42 •. 82 
PEK 90 43.79 43.93 
PEK Ml80 160 180 
PEK e2 180 
.19 .30 
PEK e 2 90 .28 .29 
u.s. CT .521 
u.s. ACD 3.53 






















































Week No. !Baseline 3 6 





7A Ml80 .173 175 
7AMS -2.25 -2.75 
14B 1.25 1.25 
21R 2.50 2.25 
K 180 43.00 43.87 
K 90 44.37 44.50 
K Ml80 173 180 
PEK 180 43.37 43.73 
PEK 90 44.34 44.96 
PEK Hl80 160 175 
PEK e2 180 .06 . 
.49 
PEK e 2 90 .07 .55 
u.s. CT .525 .525 
u.s. ACD 3.208 3.210 
u.s. AL 23o901 23.912 
CL Res. .2 






























14 17 20 . 23 























Week No. !Baseline 3 6 





7A Ml80 180 180 
7AMS -2.25 -2.75 
14B 1.25 1.25 
21R 2o50 2.25 
K 180 43.00 43.87 
K 90 44.37 44.50 
K Ml80 7 180 
PEK 180 43.09 43.·80 
PEK 90 44.65 44.63 
PEK Ml80 4 165 
PEK e2 180 o04 .42 
PEK e 2 90 .14 .35 
u.s. CT .522 .524 
u.s. ACD 3.143 3.148 
u.s. AL 23.966 23.852 
CL Res. .2 







































































PEK e2 180 

























































14 17 20 . 23 
0,67 0,50 0,50 
-1.25 -1.25 -1.50 
-0,25 -0,75 -1.00 
028 033 045 
-0.75 -1.25 -1.00 
+1.25 . +2.00 +1.50 
+1.50 +2.75 +0.50 
' 
41.50 41.37 41.75 
41.25 41.50 42.00 
160 170 180 
' 41.56 41.28 41.74 ' 
41.47 41.76 42.00 
170 180 180 
0,19 0,06 0.22 
~0.11 -0.05 0,06 
0,35 0.32 0,30 























PEK e2 180 




















































Patient -~n~·~H~·-----------­Eye RIGHT 
Age '30 
Sex F 
14 17 20'. 23 
0.67 0.80 0.80 
-1.25 -1.25 -1.00 
-0.25 
165 146 170 
-0.50 -1.00 -1.00 
+1.25 +2.00 +1.50 
+1.50 +2.75 +0.50 
41.50 41.62 42.25 
40.62 41.75 42.75 
042 180 180 
40.70 41.21 41.54 
41.30 41.74 42.12 
020 005 040 
o.o8 o.o5 0.15 
. 
-0.03 0.02 0.09 
0.35 0.32 0.30 

















PEK e2 180 




















































11 14 17 20 . 23 
. • 1 .. 29 1.0 .• 67 
-3.25 -2 .. 00 -.so -.75 
-2.50 -1 .. 50 -.so -.so 
180 180 180 180 
-2.62 -1.75 -.75 -.62 
1.75 1.75 2.00 1.2S 
3.75 2.75 3.75 3.00 
I 
46.62 45.50 45.37 45.50 
46.25 45.00 45.25 45.25 
180 180 180 180 
45.20 45.20 i 




.30 o30 .32 .32 

















PEK e2 180 



































11 14 17 20·. 23 
0.1 .33 0.5 0.1 . 
-3.25 -1.75 -1.2!: -2.50 
-2.75 -2.25 -1.2!: -1.50 
20 165 180 45 
-3.00 -2.00 -1.25 -2.00 
1.75 1.75 2.00 1.25 
3.75 2.75 3.75 3.00 
I 
46.50 45.50 46.00 46.00 
46.00 45.00 45.50 45.25 
180 180 28 180 





.30 .30 .32 .32 





















PEK e2 180 























































11 14 17 20 23 
0.67 1.33 0.67 
-0.50 -0.25 -0.75 
-0.75 -1.00 -0.75 
180 135 180 
-1.00 o.oo -0.75 
1.75 .75 1.25 
2.50 2.50 2.50 
42.12 42.00 42.87 
43.37 43.50 43.87 
180 180 180 
42.73 42.49 42.48 
43.91 43.51 43.80 
160 160 160 
0.01 0.02 0.03 






















P!K e2 180 



















































Patient N. H. ~~~------------Eye RIGHT 
Age 22 
Sex F 
11 14 17 20 23 
0.67 1.00 0.50 
-1.00 -0.50 -0.75 
-1.00 o.oo -0.75 
1.80 180 180 
-1.00 -0.25 -0.75 
+1.75 +.75 1.25 
+2.50 +2.50 2.50 
42.12 42.00 42.62 
43.37 42.62 43.00 
180 180 180 
42.28 42.01 41.93 : 
43.27 42.83 43.09 
010 180 165 
0.05 0.04 -0.02 




0.32 0.32 0.35 

















PEK e 2 180 























































11 14 17 20 23 
.4 .55 .5 .67 
-1.75 -1.50 -1.75 -1.75 
-1.00 -1.25 -1.25 -1.75 
155 155 150 
-2.00 -1.75 -1.75 -1.75 
+0 •. 50 +1.00 +1.00 +1.75 
+2.50 +2.25 2.25 +2.75 
45.00 44.50 44.12 44.25 
45.75 45.50 45.50 44.75 
010 018 020 015 
44.32 44.55 44.94 44.48 : 
45.56 45.58 46.16 45.82 
170 175 155 180 
.03 .18 -.05 -.os 
.34 .31 .09 .07 
0 52f .52: 
3 .48( 3.354 
23. 29 . 23.358 
35% 35% 35% 35% 

















PEK e2 180 










































































11 14 17 20 23 
.67 .70 .75 .67 
-1.50 -1.50 -1.50 -1.50 
-.so -1.00 -.75 -1.00 
020 025 015 030 
-1.75 -1.50 -1.75 -2.00 
+0.~0 +1.00 +1.00 +1.75 
+2.50 +2.25 2.25 2.75 
44.75 44.50 44,37 44.00 
45.50 45.50 45.25 45.37 
158 163 167 163 
44.74 44.81 44.76 44.47 : 
45.67 45.93 46.11 46.18 
005 175 180 010 
.08 .06 -.02 -.12 




35% 35% 35% 35% 


















PEK e 2 180 



















































Patient V. M. --~~-------------Eye LEFT 
Age 29 
Sex F 
11 14 17 20 23 
1.33 1.33 0.80 
o.oo o.oo -0.25. 
o.oo o.oo -0.25 
180 180 180 
o.oo -0.50 -0.25 
2.00 1.00 1.50 
2.75 2.75 2.00 
43.25 43.75 43.75 
44.37 44.50 44.75 
180 003 175 
43.45 43.49 43.82 
44.24 44.32 45.04 
015 005 180 
-0.14 0.04 0 .. 19 




0.33 0.35 0.32 




















PEK e2 180 























































11 14 17 20 23 
1.00 1.33 o.8o 
o.oo 0.25 -0.50 
0.50 0.25 -0.25 
180 180 170 
o.oo 0.25 -0.50 
2.00 1.00 1.50 
2.75 2.75 2.00 
43.25 43.75 44.00 
44.00 44.75 44.50 
175 173 175 
43.50 43.72 43.97 : 
44 .12· 44.16 44.91 
165 180 170 
-0.11 0.14 0.04 




0.33 0.35 0.32 


















PEK e2 180 



















































11 14 17 20 23 
.5 .4 .a 
-2.00 -1.7~ -1.50 
-1.50 -1.25 -1.25 
40 15 25 
-2.00 -1.87 -2.00 
1.25 ~50 .• 75 
2.75 2.25 
42.25 42.50 42.75 
42.75 42.50 42.75 
180 180 180 
42.42 42.47 42.52 
42.52 42.38 42.50 
180 180 10 
.13 .11 .26 




.35 .35 .37 




















PEK e 2 180 























































11 14 17 20 23 
.a .5 .a 
-1.50 -1.75 -1.75 
. 
-1.00 -1.00 -1.00 
20 05 1aO 
-1.50 -1.37 -1.75 
1.z5 .so .75 
2.75 2.25 
42.25 42.50 42.75 
42.00 42.25 42.75 
1aO 05 1aO 
42.43 42.17 42.60 ; 
41.96 42.57 42.14 
155 40 150 
.20 .12 .13 
.14 .1a .06 
3.727 
24.742 
.35 .35 .35 






















PEK e2 180 




































+1.25 +0. 75 
+2.50 +3.00 














Patient L. L. --~~~-----------Eye LEFT 
Age 17 
Sex F 
. ' . 
14 17 20 23 
0.2 0.4 0.67 
-1.50 -1.50 -1.50 
. 
-2.00 -1.50 -1.50 
175. 180. 180. 
-1.50 -1.75 -1.50 
+1.00 +1.25 +1.25 
+2.75 +3.00 +2.75 
44.25 44.50 44.25 
45.75 45.25 45.00 
180. 180. 180. 
44.37 44.12 44.25 : 
45.50 45.37 45.12 
180. 180. 10 
-0.13 -0.15 0.05 




0.35 0.325 0.325 
28. 28. 28. 
Week No. 1Base1ine 3 
VA w/o CL 0.05 0.067 
7A 180 -2.50 -2.50 
7A 90 -2.50 -2.25 
7A Ml80 180. 180. 
7AMS -2.50 -2.50 
148 +1.50 +1.25 
21R +2.75 +2.75 
K 180 44.00 43.50 
K 90 44.00 44.25 
K M180 180 180. 
PEK 180 44.12 43.87 
PEK 90 45.12 44.62 
PEK Ml80 10. 180. 
PEK e 2 180 -0.01 0.1 
PEK e 2 90 -0.04 -0.03 
u.s. CT 0.566 
u.s. ACD 3.600 
u.s. AL 23.836 
CL Res. 0.325 








































































Week No. ~Baseline 3 
VA w/o CL 0.67 0.80 
7A 180 -1.75 -1.50 
7A 90 -1.00 -0.50 
7A Ml80 160 160 
7AMS -1.12 -1.00 
14B +0.75 +0.25 
21R +2.25 +1.50 
K 180 43.25 43.00 
K 90 42.25 42.25 
K Ml80 168 154 
PEK 180 43.14 
PEK 90 42.21 
PEK Ml80 5 
PEK e2 180 .14 
PEK e 2 90 .06 
u.s. CT .530 
u.s. ACD 3.109 
u.s. AL 23.948 
CL Res. 30 
































































PEK e2 180 












































































Week No. Baseline 3 
VA w/o CL ol .2 
7A 180 -2.00 -2.00 
7A 90 -1.50 -1.50 
7A Ml80 180 180 
0 
-2.00 -2.00 7AMS 
14B 1.25 1/25 
21R 2.50 3.00 
K 180 42.00 41.50 
K 90 42.50 42.50 
K · Ml80 180 180 
PEK 180 41.68 41.52 
PEK 90 42.25 42.06 
PEK Ml80 150 155 
PEK e2 180 .16 .09 
PEK e 2 90 .19 .12 
u.s. CT .524 .533 
u.s. ACD 2.89 3.08 
u.s. AL 23.99 23.99 
CL Res. .32 





























11 14 17 20 23 
.33 .40 .so 
-2.50 -2.25 -2.00 
. 
-1.75 -1.75 -1.75 
180 180 180 
-2.50 -2.50 -2.00 
.~0 1.25 1.00 
2.00 4.00 3,50 
42.00 41.25 41.75 
42.75 41.62 42.25 
180 180 180 
41.89 41.33 41.66 : 
42.38 42.19 42.11 
170 170 180 
.16 .11 .20 
.11 .16 .11 
.33 .33 • 34 






















PEK e2 180 
PEK e 2 90 


















































Patient D. G. 
Eye ~~~H~-----------RIG T 
Age 24 
Sex F 
11 14 17 20 23 
.33 .so .so 
-2.SO -2.2S -2.00 
. 
-1.75 -1.7S -1.7S 
180 180 180 
-2.SO -2.SO -2.00 
.so 1.2S 1.00 
2.00 4.00 3.SO 
42.00 40.87 42.00 
42.75 42.2S 42.SO 
180 180 180 
41.71 41.32 41.3S 
42.27 42.3S 42.36 
020 010 10 
.29 .1S .13 
.29 .14 .16 
.33 .33 .34 



















PEK e2 180 
PEK e 2 90 
u.s. CT 
u.s. ACD 





































































11 14 17 20 23 
.4 .25 .80 ,67 .1.0 
-1.75 -1.25 -1.75 -1.00 -1.25 
-1.75 -1.25 -1.75 -1.00 -1.25 
180 180 180 180 180 
-1.50 -1.50 -1.75 -1.00 -1.25 
1.00 .so .75 .so 1.00 
2.00 3.00 3.00 3.00 3.25 
43.37 43.00 42.87 43.00 43.50 
44.25 43.75 43.75 43.62 44.25 
180 180 180 180 180 
43.27 43.03 43.28 42.99 
44.14 43.75 44.02 43 .. 84 
175 175 180 180 
.16 .06 .10 .02 




.28 .32 .31 .30 .35 



















PEK e2 180 





































































11 14 17 20 23 
.29 .29 .67 .s .1.0 
-1.7S -1.SO -2.00 -1.00 -1.25 
-1.SO -1.2S -2.2S -1.2S -1.25 
17S 17S 1S 6 180 
-1.SO -1.2S -2.00 -1.00 -1.2S 
1.00 .so .7S .so 1.00 
2.00 3.00 3.00 3.00 3.25 
43.37 43.00 42.SO 43.00 43.SO 
44.12 43.62 43.7S 43.75 44.00 
180 20 180 170 180 
43.12 42.87 42.93 43.12 ; 
43.8S 43.45 43.92 43.99 
17S 17S s 180 
.1S .19 .20 .06 




.28 .32 .31 .30 .3S 
18 28 37 .38 38 
Week No. Baseline 
VA w/o CL .075 
7A 180 -3.00 
7A 90 -3.25 




K 180 42.00 
K 90 . 42.37 
K Ml80 180 
PEK 180 42.15 
PEK 90 43.12 
PEK Ml80 15 
PEK e2 180 .16 
PEK e 2 90 .06 
u.s. CT .515 
u.s. ACD 3.293 

















































11 14 17 20 23 
.1 .2 .33 .25 .2 
-3.75 -3.00 -3.00 -2.25 -2.25 
-4.00 -3.25 -3.00 -2.25 -2.25 
177 170 180 180 180 
-4.00 -3.00 -3.00 -2.25 -2.00 
2.50 2.25 2.25 1.50 1.50 
3.50 3.00 3.00 3.00 3.00 
42.12 42.12 42.00 41.37 42.00 
43.12 42.87 43.00 42.25 42.50 
10 13 180 180 180 
42.44 42.20 42.26 41.62 
43.20 43.04 42.94 42.46 
170 180 180 180 
.28 .22 .26 -.03 




.3 .35 .35 .32 .34 





















PEK e 2 180 






































































11 14 17 20 23 
.075 .1 .33 .29 .25 
-3.00 -3.00 -3.00 -2.00 -2.00 
. 
-3.50 -3.50 -3.00 -2.00 -2.00 
4 180 180 180 180 
-4.00 -3.25 -3.00 -2.00 -2.00 
2.~0 2.25 2.25 1.50 1.50 
3.50 3.00 3.50 3.00 3.00 
42.62 42.25 41.75 41.25 41.75 
42.87 42.87 42.75 42.25 43.00 
175 180 180 180 180 
42.26 41.82 41.83 41.53 
43.20 43.04 42.94 42.46 
180 175 175 180 
.21 .23 .25 .25 
.13 .21 .12 -.07 
.512 
.3 .35 .35 .32 .36 

















PEK e2 180 


















































Patient c. F. ~~~------------Eye LEF!l' 
Age 22 
Sex F 
11 14 17 20 23 
1.33 1.33 0.50 1.00 
-0.75 -0.25 -0.75 -1.00 
. 
-0.25 -0.50 -1.00 
142 007. 165 180 
-0.25 -0.25 -0.75 -0.75 
+1.~5 +1.25 +1.25 +1.75 
+2.25 +2.25 +2.50 +2.75 
42.50 42.75 42.75 42.87 
43.00 42.75 43.37 43.37 
005. 180 180 180 
42.70 43.14 42.88 
43.13· 42.77 43.36 
180 140 180 
0.22 0.23 0.13 




0.35 0.35 0.325 0.33 



















PEK e2 180 




































































Patient c. F. --~~~----------Eye RIGHT 
Age 22 
Sex 
11 14 17 20 23 
0.67 o.8o 0.33 0.50 
-0.50 -1.00 -0.75 -1.75 
-0.75 -o.5o -1.25 -1.25 
180 030 140 030 
-1.00 -1.00 -1.00 -1.25 
+1.25 +1.25 +1.25 +1.75 
+2.25 +2.25 +2.50 +2.75 
42.62 42.75 43.00 43.00 
43.00 43.00 43.00 43.37 
175 153 180 180 
42.75 42.81 42.86 
43.13 43.30 43.34 
180 005 005 
0.14 0.13 0.16 




0.325 0.35 0.·35 0.33 

















PEK e2 180 



































































Patient B. H. ~~~------------Eye LEFT 
Age 15 
Sex M 
11 14 17 20 23 
0,2 0.2 0.25 0,25 0.25 
-2.75 -2.25 -2.00 -3.00 -2.75 
. 
-3.00 -2.50 -2.25 -2.50 -1.75 
165 160 170 015 165 
-2.75 -2.25 -2.25 -2.75 -2.25 
+1.50 +1.75 +0.75 +1.00 +1.25 
+3.25 +3.00 +2.50 +2.75 +2.75 
44.25 44.00 44.00 44.50 44.00 
45.00 44.00 44.50 45.00 44.25 
170 180 180 180 005 
44.05 43.66 44.02 43.75 
44.75 44.34 45.06 44.55 
180 175 175 180 
0.32 0.26 o.o8 0.28 
0.20 0.24 0.20 0.28 
0,527 0.526 0.515 
3.568 3.497 
24.602 24.384 
0.35 0.35 0.37 0.32 0.35 
28 28 29 38 28 
Week No. !Baseline 
VA w/o CL 0.1 
7A 180 -2.00 
7A 90 -1.75 
7A M180 005 
' 7AMS -1.75 
14B +1.25 
21R +2.75 
K 180 43.12 
K 90 43.75 
K Ml80 170 
PEK 180 43.33 
PEK 90 43.78 
PEK Ml80 160 
PEK e2 180 Oo34 
PEK e 2 90 0.12 
u.s. CT 0.505 
u.s. ACD 3.594 

















































11 14 17 20 23 
' 
0.2 0.2 0.33 0.28 0.28 
-2.75 -2.00 -1.25 -2.00 -2.00 
-3.50 -2.00 -1.25 -2.00 -1.75 
015 180 180 180 010 
-3.12 -2.00 -1.75 -2.25 -1.75 
+1.50 +1.75 +0.75 +1.00 +1.25 
+3.25 +3.00 +2.50 +2.75 +2.75 
44.25 43.75 44.00 44.00 43.87 
45.00 44.00 44.00 44.75 44.37 
160 174 180 165 170 
43.90 43.83 43.81 43.86 
44.99 44.63 44.81 44.54 
180 165 165 180 
0.38 0.27 0.15 0.39 




0.325 0.35 0.37 0.325 0.35 
37 36 29 38 28 
Week No. !Baseline 3 
VA w/o CL 0.2 0.67 
7A 180 -2.25 -2o25 
7A 90 -2.00 -2.25 
7A Ml80 015 180 
' 
-2.12 -2.50 7AMS 
14B +2.00 +2.50 
21R +3.50 +4.00 
K 180 44.00 44.37 
K 90 45.37 45.50 
K Ml80 180 180 
PEl< 180 44.11 44.35 
PEK 90 45.41 45.39 
PEK Ml80 180 170 
PEK e 2 180 0.13 0.03 
PEK e 2 90 0.29 0.20 
u.s. CT .493 
u.s. ACD 3,365 
u.s. AL 23.642 
CL Res. .32 





























11 14 17 20 23 
0.33 0.50 .67 
-2.25 -2o00 -2.00 . 
1.75 -1.50 -1.50 
180 030 15 
-2.00 -1.75 -2,00 
+2.25 +1.50 1.75 
+3.50 +3.50 3.25 
44.25 44.00 44.50 
45.25 45.50 45.75 









.32 .32 .32 





















PEK e2 180 























































11 14 17 20 23 
0.4 0.33 .5 
-2.50 -2.50 -2.50 
-1.50 -1.25 -1.75 
180 180 175 
-2.00 -1.87 -2.25 
+2 •. 25 +1.50 1.75 
+3.50 +3.50 3.25 
44.00 44.00 44.50 
44.25 44.75 45.25 
180 180 180 
43.92 44.15 ; 
44.4~ 44.89 
175 010 






.32 .32 .32 
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Overall Incidence of Each Grade Level 
Reported Between January and November, 
1977. (in per cent of total observa-
tions) 
Category Grade Levels 
0 0.5 1.0 1.5 2.0 3~0 . 4.0 
Corneal 
' I Edema 82.3 11.9 4.0 0.6, 0.8 0.4 
I 
Fluorescein I Retention 64.0 5.6 13.3 
---, 13.9 2.8 9.2 
I 
Conjunctival 
Injection 44.0 26.7 26.5 2.2 0.2 
J 
Perilimbal 
Injection 42.0 34.7 20.9 2.4 
J 0 to 5 6 to 10 11 to 14 15 + (sec.) 
Tear Break-























INCIDENCE OF GRADE LEVEL DURING ALL VISITS 
BETWEEN JANUARY AND NOVEMBER, 1977, (IN PER 























6 to 10 11 to 14 











The following tables tally the number of patients in each respective group 
who, at one time or another, developed a certain grade level and the num-
of occurances of each grade level in each respective group. The third col-
umn represents the per cent occurance of each grade level within each ex-
perimental group. Data is taken from visits between January and November, 
1977. 
Key: 
Pts. = number of patients who developed the grade level 
#Occur. = number of occurances of the grade level 
%Freq. = per cent occurance of the grade level in the group 
CORNEAL EDEMA 
Grade Pts. #Occur. %Freq. Pts. #Occur. %Freg. Pts. #Occur. %Freg. 
0.0 10 138 83.2 10 109 82.6 12 170 82.5 
0.25 1 2 1.2 3 2 1.5 1 3 : 1. 5 
0.5 6 12 7.2 6 17 12.9 6 24 11.7 
0.75 - 1.0 4 8 4.8 3 4 3.0 3 6 2.9 
1.5 1 2 1.2 - - - 1 1 0.5 
2.0 1 2 1.2 
- - -
1 2 1.0 
3.0 
4.0 1 2 1.2 
5.0 






-· ---- ----- ~ --------' 
Project I Project II Project II 
Orthokeratology Control Orthokeratology 
B. FLUORESCEIN RETENTION 
Grade Pts #Occur. %Freq. Pts. #Occur. %Freg. Pts. #Occur. %Freg. 
0.0 10 114 68.7 10 81 61.4 12 147 71.4 
0.5 2 9 5.4 2 7 5.3 4 10 4.9 
1.0 8 20 12.0 7 17 12.9 9 15 7.3 
1.5 2 2 1.2 1 3 2.3 2 5 2.4 
2.0 5 14' 8.4 8 23 17.4 6 23 11.1 
3.0 3 7 4.2 - - - 2 6 2.9 
4.0 
- - -
1 1 0.7 
5.0 
6.0 
- - - - - - - - -
f--.1 
7.0 \0 
- - - - - - - - -
H 
I"bb 99-9 132 100.0 25"b 100.0 
c. CONJUNCTIVAL INJECTION 
0.0 7 49 29.5 9 62 47.0 10 115 55.8 
0.25-0.50 8 47 28.3 6 30 22.7 10 57 27.7 
0.75-1.00 10 60 36.1 6 39 29.5 7 33 16.0 
1.25-1.50 3 8 4.8 1 1 0.8 
2.0 "1 2 1.2 





ITO 99-9 132 100.0 -205 100.0 
L_ 
_j 
Project I Project II Project II 
Orthokeratology Control Orthokeratology 
D. PERILIMBAL INJECTION 
Grade Pts. #Occur. %Freq. Pts. #Occur. %Freq. Pts. #Occur. %Freq. 
0.00 7 53 32.0 9 67 50.7 7 82 39.8 
0.25 1 6 3.6 2 10 7.6 2 10 4.9 
0.50 9 54 32.5 7 28 21.2 11 74 35.9 
0.75 1 2 1.2 
- - -
1 2 1.0 
1.0 9 43 25.9 7 24 18.2 8 36 17.4 
1.5 1 3 1.8 
2.0 4 r" 3.0 1 3 2.3 1 2 1.0 ::> 
3.0 
- - - - - - - - -
I-' 
\D 4.0 - - - - - - - - - f\) 
Ibb 100.0 132 100.0 2"6"i) 100.0 
~ 
..:!.. TEAR BREAK-UP TIME 
15++ 10 136 81.9 10 94 71.2 12 137 66.5 
13-14 1 2 1.2 2 2 1.5 3 6 2.9 
10-12 5 19 11.4 8 20 15.2 10 46 22.3 
7-9 5 8 4.8 3 9 6.8 5 9 4.4 
4-6 1 1 ' 0. 6 1 7 5.3 2 7 3.4 
0-3 - - - - - - 1 1 0.5 
Ibb 99-9 132 100.0 206 100.0 
l 193 
I 
INCIDENCE OF BIOMICROSCOPY GRADE LEVELS 
IN PROJECT II PATIENTS 
FROM JANUARY TO NOVEMBER, 1977. 
Key: 
# pts. = number of patients developing a grade level at one 
time or another 
# occa. = number of reported cases of that grade level 
% occur. = per cent occurance per group of that grade level; 
= # occa. divided by total number of observations 
made on that specific group. 
GROUPS 
CONTACT LENS CONTROL ORTHOKERATOLOGY 
GRADE 
# :QtS. #occa. %occur. # :QtS. #occa. %occur. 
EDEMA 
0.0 10 109 82.6 12 170 82.5 
1.0 8 23 17.4 7 33 16.1 
2.0 0 0 0.0 1 3 1.5 
3.0 0 0 0.0 0 0 0.0 
4.0 0 0 0.0 0 0 0.0 
5.0 0 0 0.0 0 0 0.0 
132 100.0 206 100.0 
FLUORESCEIN 
RETENTION 
o.o 10 81 61.4 12 147 71.4 
1.0 7 24 18.2 10 25 12.2 
1.5 1 3 2.3 2 5 2.4 
2.0 8 23 17.4 6 23 11.1 
3.0 0 0 0.0 2 6 2.9 
1 4.0 1 1 0.7 0 0 0.0 




GRADE CONTACT LENS CONTROL ORTHOKERATOLOGY 
CONJUNCTIVAL# pts. # occa. %occur. # EtS. #occa. %occur. 
INJECTION 
0.0 9 62 47.0 . 10 .1l5 55.8 
1.0 7 69 52.2 10 90 43.7 
2.0 0 0 0.0 0 0 0.0 
3.0 0 0 0.0 1 1 0.5 
4.0 0 0 0.0 0 0 o.o 
132 100.0 206 100.0 
PERILIMBAL 
INJECTION 
0.0 9 67 50.7 7 82 39.8 
1.0 9 62 47.0 11 122 59.2 
2.0 1 3 2.3 1 2 1.0 
3.0 0 0 0.0 0 0 0.0 
4.0 0 0 0.0 0 0 0.0 
132 100.0 206 100.0 
BREAK-UP 
TIME (sec.) 
15 10 136 81.9 12 137 66.5 
13 - 14 2 2 1.5 3 6 2.9 
10 - 12 8 20 15.2 10 46 22.3 
7 - 9 3 9 6.8 5 9 4.4 
4 - 6 1 7 5.3 2 7 3.4 
1 - 3 0 0 0.0 1 1 0.5 




INCIDENCE OF GRADE LEVELS (IN PER CENT) 
1 FOR EACH RESPECTIVE GROUP 
I CATEGORY GRADF. 
4 _o_ 1 ~ 2 _3_ 
CORNEAL 
EDEMA 
Total Observed 82.3 15.9 1~4 o.o 0.4 
Control Gp. 82.6 17.4 0.0 0.0 0.0 
Ortho-K Gp. 82.5 16.1 1.5 0.0 0.0 
FLUORESCEIN 
RETENTION 
Total Observed 67.8 15.5 2.0 11.9 2.6 0.2 
Control Gp. 61.4 18.2 2.3 17.4 0 . 0 0 . 7 
Ortho-K Gp. 71.4 12.2 2.4 11.1 2.9 0.0 
CONJUNCTIVAL 
INJECTION 
Total Observed 44.4 53.2 2.2 0.2 0.0 
Control Gp. 47.0 52.2 0.8 0.0 0.0 
Ortho-K Gp. 55.8 43.7 0.0 0.5 0.0 
PERILIMBAL 
INJECTION 
Total Observed 42.0 55.6 2.4 0.0 0.0 
Control Gp. 50.7 47.0 2.3 0.0 0.0 
Ortho-K Gp. 39.8 59.2 1.0 0.0 0.0 
BREAK -UP TIME 0 lo G 7 Lo 9 10 tu 14 15 _Qlus 
Control Gp. 5.3 6.8 16.7 71.2 




l BIOMICROSCOPY RESULTS 
-l Patients Only Showing Low· Grade Levels 
I 
Category Project I Project II Project II 
Orthokeratolog;t Control Orthokeratolog;t 
(Total 10) (Total 10) (Total 12) 
Corneal Edema 
Grade 0 2 2 5 
0 to 0.5 6 6 9 
Fluorescein 
Retention 
Grade 0 2 2 2 
Conjunctival 
In.1ection 
Grade 0 0 3 2 
0 to 0.5 0 3 5 
0 to 1. 0 6 10 11 
Periiimbal 
In,jection 
I Grade 0 1 1 1 0 to 0.5 1 3 4 
0 to 1. 0 6 9 11 
J Tear Break-
Up Time 




L_ L_ L__ L_ L__ L___ I ~
MEA~ CYLINDER VALUES - FIRST AND LAST SESSION 
Group 
Project I Orthokeratology 
Start 
Finish 
Project II Control 
Start 
Finish 






0.0139 + 0.465 0.424 + 0.354 
- -
0.1110 + 0.430 0.533 ±. 0.419 
0.132 + 0.617 0.536 ±. 0.521 
0.025 ±. 0.584 0.513 ±. 0.513 
0.130 + 0.469 0.539 + 0.514 
0.156 + 0.300 0.798 + 0.555 
...:.._j _j _j _:____.] 
Keratometry 
0.490 + 0.395 f-' 
1.0 
~ 
0.570 + 0.445 
0.586 + 0.665 
0.412 ±. 0.585 
0.477 + 0.611 
0.500 + 0.558 
l__ ,___ __ J 
MEAN MERIDIAN OF 7A NEAREST 180 
(in degrees) 
Range 
Grou£_ Baseline High Low 
Project I Orthokeratology 1.4o· t 12.19 4.30 + 22.12 179.16 + 23.08 
Week 55 Week 52 
Project II Control 4.05 ±. 17.70 4.50 + 11.41 170.25 + 22.36 
Week 11 Week 17 
Project II Orthokeratology 2.00 + 10.16 5.00 + 12.25 177.22 + 16.28 
Week 3 Week 17 
MEAN MERIDIAN OF PEK NEAREST 180 
I-' 
Project I Orthokeratology 176.95 + 18.48 2.10 + 2.72 171.25 + 15.75 1..::) (X) 
Week 69 Week 66 
Project II Control 178.20 ±. 20.00 10.00 + 19.00 170.71 + 20.17 
Week 11 Week 14 
Project II Orthokeratology 3.45 :!:. 14.17 3.45 + 14.17 171.73 + 12.75 
Week 1 Week 3 
MEAN MERIDIAN OF KERATOMETRY NEAREST 180 
Project I Orthokeratology 1.30 ±. 3.72 3.83 + 9.21 173.11 + 14.86 
Week 69 Week 60 
Project II Control 3.38 + 11.92 3.60 + 12.55 177.50 + 7.07 
Week 3 · Week 11 
Proje~t II Orthokeratology 177-54 ±. 8.60 2.58 + 10.42 177.54 + 8.60 
Week 3 Week 1 
L_ L__ L__ L_ 
Group 
Project I Orthokeratology 
Project II Control 
Project II Orthokeratology 
CONTACT LENS POSITION 
Most Nasalward 
7.30 + 0.67 
Week oO 
7.40 + 0.63 
Week E" 




7.71 + 0.95 
Week 66 
8.00 + 0.00 
Week 11 
7.95 + 0.65 
Week 2o 




L._ L__ L_ t__ t__ ~ __j __j ~ 
CONTACT LENS POSITION 
MEAN VERTICAL POSITIONING 
Grou.2_ Baseline V.'eek 14 (60) Week 20 (66) 
Project I Orthokeratology 2.64 + 0.99 1.85 ·+ 0.38 2.09 + 0.54 
Project II Control 2.39 + 0.50 2.07 :t. 0.70 2.00 + 0.52 
Project II Orthokeratology 2.25 + 0.79 1.78 + o·.92 2.09 :t. 0.81 I\) 0 
0 
MEAN HORIZONTAL POSITIONING 
Project I Orthokeratology 7.41 + 0.62 7.30 ±. 0.67 7.71 + 0.95 
Project II Control 7.50 + 0.62 
----- -----
Project II Orthokeratology 7.71 + 0.55 ----- 7.95 ±. 0.65 
L__ L_ L__ __] __J 
PROJECT I ORTHOKERATOLOGY 
CORRELATION PER CENT SIGNIFICANCE 
n X VARIABLE Y VAR:ABLE COEFFICIENT VARIANCE t-VALUE LEVEL (df = n-2) 
7 VA CL Position 0.062 0.1383 > 0. 20 (V) 
7 VA CL Position 0.899 80.75 4.579 0.01 (H) 
7 VA Tear -0.030 0.09 -0.067 > 0.20 
Reservoir 
7 VA e 2 at 90 -0.560 31.39 -1.513 0.20 f\) 
0 
2 1--' 
7 VA e at 180 -0.201 4.06 -0.406 > 0. 20 
5 VA Axial Length 0.135 1.82 0.236 0.10 (US) 
7 VA 7AMS 0.774 59.94 2.735 0.05 
7 VA Keratometry 
at 90 
0.019 0.03 0.0~2 > 0.20 
7 VA Keratometry 
at 180 
0.~37 19.07 1.085 >0.20 
L_ L_ L._ ...___ 
-----
n X VARIABLE Y VARIABLE 
7 VA CL Position (V) 
7 VA CL Position 
(H) 
7 VA Tear 
Reservoir 
7 VA 2 at 90 e 
7 VA 2 at 180 e 
5 VA Axial Length (US) 
7 VA 7AMS 
7 VA Keratorr.etry 
at 90 
7 VA Keratometry 
at 180 
PROJECT II CONTROL 
CORRELATION PER CENT 
COEFFICIENT VARIANCE t-VALUE 
(r2(100)) 
0.179 3.20 0~407 
0.197 3.87 0.448 
0.764 58.40 2.649 
-0.662 43.88 -1.977 
-0.714 51.06 -2.284 
-0.544 29.61 -1.123 
0.680 46.21 2.073 
0.733 53.71 2.408 
0.710 50.45 2.256 




LEVEL (df = n-2) 
') 0. 20 










































at 90 e 
2 








_j ~ __j __j __j 
PROJECT II ORTHOKERATOLOGY 
SIGNIFICANCE 
CORRELATION PER CENT t-VALUE LEVEL (df = n-2) 
COEFFICIENT VARIANCE 
-0.866 74.94 -3.867 0.02 
0.404 16.34 0.988 ) 0. 20 
0.760 57.72 2.613 0.05 
-0.819 67.16 -3.198 0.05 r.J 
0 
w 
-0.795 63.25 -2.933 0.05 
-0.630 39.70 -1.405 ")-0. 20 
0.886 78.44 4.265 0.01 
0.733 53.67 2.407 0.10 
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